Comparative study of Short term Vs Long term use of Prophylactic Antibiotics in Caesarean Section by Subha, S S
COMPARATIVE STUDY OF SHORT TERM 
VS
LONG TERM USE OF PROPHYLACTIC 
ANTIBIOTICS IN LSCS
Dissertation submitted to 
THE TAMILNADU DR. M.G.R. MEDICAL UNIVERSITY
In partial fulfilment of the regulations
for the award of the degree of
M.D. BRANCH-II
OBSTETRICS AND GYNAECOLOGY
GOVT. R.S.R.M. LYING-IN HOSPITAL AND
GOVT. STANLEY MEDICAL COLLEGE & HOSPITAL





This  is  to  certify  that  this  dissertation titled  “SHORT TERM VS 
LONG  TERM  USE  OF  PROPHYLACTIC  ANTIBIOTICS  IN 
CAESAREAN  SECTION”  is  a  bonafide  record  of  work  done  by 
Dr.Mrs. Subha .S.S. D.G.O., during the  period of her Post graduate study 
from  May  2007  to  March  2009  under  guidance  and  supervision  in  the 
Department  of  Obstetrics  and  Gynaecology,  Raja  Sir  Savalai  Ramasamy 
Mudaliar  Hospital,  Stanley Medical  College Hospital,  Chennai-600013 in 
partial fulfilment of the requirement for  M.D. Branch-II Obstetrics and 
Gynaecology Examination of the Tamilnadu Dr. M.G.R. Medical University 
to be held in March 2009.





Dr.M.MOHANAMBAL, M.D. D.G.O., 
HOD, Superintendent, 







I  express  my  sincere  thanks  to  the  Dean, 
Dr.J.MOHANASUNDARAM, M.D.,  D.N.B.,  Ph.D.,  for permitting me to utilize all 
the resources at his disposal.
I  express  my  sincere  and  heartfelt  gratitude  to  Professor 
Dr.M.MOHANAMBAL, M.D. D.G.O., HOD, Government RSRM Hospital, for her 
encouragement, support and guidance during my study.
I also express my heartfelt deep sense of gratitude to  Prof.Dr.AMRITA 
PRISCILLA  NALINI,  M.D.,  D.G.O. Additional  Professor  of  Obstetrics  & 
Gynaecology,  Government  Stanley  Medical  College  for  her  constant 
encouragement, support, valuable comments and timely suggestions to shape 
this work.
I am extremely grateful to Prof. Dr.P.SASIREKHA, M.D. D.G.O., Additional 
Professor of Obstetrics & Gynaecology, Government Stanley Medical College for 
her encouragement,  support and guidance during my study.  
3
I  am  extremely  grateful  to  Prof.Dr.C.  R.  ANURADHA, M.D.,  D.G.O., 
Additional Professor of Obstetrics & Gynaecology, Government Stanley Medical 
College for her constant encouragement, support, valuable comments and timely 
suggestions to shape this work.
I express my sincere and heartfelt gratitude to                          Prof.Dr.C. 
K.  RAJINI, M.D.D.G.O., Additional  Professor  of  Obstetrics  &  Gynaecology, 
Government Stanley Medical College for her guidance and valuable support.
I  express  my  sincere  and  heartfelt  gratitude  to 
Prof.Dr.N.HEPHZIBAH  KIRUBAMANI,  M.D.D.G.O.,Ph.D., RMO,  Government 
RSRM Hospital for her guidance and valuable support throughout the course and 
the present study.





Sl.No. TITLE Page No.
1 INTRODUCTION 1
2 AIM OF THE STUDY 2
3 REVIEW OF LITERATURE 3










Prophylactic  antibiotics  in  surgery is  intended to  prevent  morbidity  and 
mortality as well as to reduce the duration and the cost of hospitalization. Despite 
the  advent  of  antibiotics,  infection  in  obstetric  practice  continue  to  cause 
problems, particularly the developing countries. The source of wound infection 
and genital tract infection after caesarean section are primarily bacteria from the 
patients  abdominal  skin  introduced  during  or  after  the  incision  and  bacteria 
ascending from the vagina before or after the operation. The infection could be 
due to cross infection. 
Ceftriaxone  is  the  third  generation  cephalosporin.  The  distinguishing 
feature of this cephalosporin is its longer duration of action (t½ 8hrs). It exerts 
potent  action  on  aerobic  gram  negative  bacteria  as  well  as  gram  positive 
bacteria. 
The present study was carried out to evaluate the efficacy and safety of 
cefriaxone in caesarean section.
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AIM OF THE STUDY
1) To assess the effectiveness of single dose antibiotic prophylaxis 
with Inj.ceftriaxone 1gm IV in controlling infections in caesarean section. 
2) To reduce the total requirement of antibiotics in LSCS cases thus 
reducing the cost of the treatment.
3) To  compare  the  effectiveness  of  ceftriaxone  with  ampicillin  and 




A large number of randomised trials have demonstrated that a single dose 
of an antimicrobial agent given at the time of caesarean delivery will  serve to 
decrease infection morbidity significantly in high-risk labouring patients as well as 
those  undergoing  elective  caesarean  delivery  (American  College  of 
Obstetricians  and  Gynecologist  2003)31 .  Postoperative  pelvic  infection  is  the 
most frequent cause of febrile morbidity and develops in upto 20% of women 
despite peripartum prophylactic antimicrobials (Goepfort and associates, 2001)  32
Gordon  HR  et  al  (1979)  showed  that  the  transplacental  passage  of 
prophylactic  antibiotic  does  not  increase  immediate  or  delayed  neonatal 
infections. Results  show that prophylactic antibiotic initiated after cord clumping 
is as effective in reducing maternal morbidity as the antibiotic initiated prior to 
surgery. 1
Itskovitz  et  al  (1979)  showed  that  the  postoperative  infection  can  be 
reduced by using prophylactic antibiotics in the immediate postoperative period. 
By this regimen, undesired placental transfer of the antibiotics to the fetus can be 
avoided. 2
GALL SA (1979) Showed that preoperative antibiotic administration being 
beneficial to the obstetric patient. 3
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Schilze  G  (1980)  showed  in  his  study  on  prophylactic  antibiotics  in 
caesasean  section,  maternal  infections  were  lower  in  the  group  given 
prophylachic antibiotics. 4
Hawrylyshyn PA etal (1981) showed that prophylactic antibiotics aimed at 
decreasing postoperative morbidity 5
 Padilla et al (1983) in a prospective, randomized study showed that there 
were  no  differences  in  the  effectiveness  of  the  antibiotic  whether  given 
preoperatively or intraoperatively, serious infections and wound infections were 
not encountered in patients receiving prophylactic antibiotic.  6
 Wallace RL (1983)  showed that  in  their  study there was a significant 
reduction in the incidence of postoperative endomyometritis in the group given 
prophylactic antibiotics, other advantage included a shorter duration of treatment 
required.  The  study  suggest  that  patients  who  undergo  emergency  primary 
caesarean section benefit from a short course of prophylactic antibiotics.  7
Periti P et al (1984) in their prospective study showed the equal efficacy of  
two short term antimicrobial prophylactic regimens in obstetrical surgery involving 
a single dose of a long acting cephalosporin, Ceftriaxone in comparison with a 
multiple dose. The differences on the incidence of infections are not statistically 
significant. 8
9
Jaffe R etal (1985) in their study on single dose antibiotic prophylaxis in 
emergency caesarean section showed that  the  incidence of  febrile  morbidity,  
endometritis and urinary tract infection were significantly lower in the group given 
prophylactic  antibiotic.  Other  benefits  of  antibiotic  prophylaxis  include  shorter 
hospital stay and no serious infections in the group given prophylactic antibiotic.  9
 Sattzman DH et al  (1985) in their study showed single dose antibiotic 
prophylaxis at cord clamping significantly reduced the incidence of endometritis 
and febeile morbidity in high risk patients undergoing caesarean section.  10
Roex  AJ  etal  (1986)  showed  that  shortcourse  antibiotic  prophylaxis  in 
caesarean  section  reduced  the  postoperative  wound  infection,  urinary  tract 
infection and preoperative antibiotic therapy. 11
Saltzman DH et al (1986) in their prospective double blind study compared 
the effectiveness of single perioperative dose of antimicrobial  prophylaxis and 
multi-dose antimicrobial prophylaxis for preventing infections in high risk patients 
undergoing ceasarean section. The single perioperative dose of antibiotic was as 
effective as three-dose regimen of antibiotic. 12
Duff P. (1987) showed that a single dose of antibiotic administered after 
the umbilical cord is clamped provides a degree of prophylaxis comparable to 
that achieved with two and three dose regiments. 13
10
Mahomed  K.(1988)showed  in  his  study  on  232  patients  undergoing 
elective lower segment caesarean section that the group receiving preoperative 
prophylactic antibiotic had significantly fewer infections, morbid event and fewer 
febrile illness and short hospital stay. 14
Mancuso (1989) evaluated the efficacy of single dose (lg iv) ceftriaxone 
(Rocephin)  in  175  patients  undergoing  emergency  caesarean  section  (62 
patients)  or  elective  caesarean  section  (113  patients).  The  overall  rate  of 
postoperative  infections  morbidity  was  8% (14/175),  with  9.6% (6/62)  of   the 
group undergoing emergency surgery and 7.0% (8/113) of the patients choosing 
elective caesarean section. 15
Galask  RP  etal  (1989)  compared  the  effectiveness  of  single  dose 
antibiotics for prophylaxis of post-caesarean infections, combined data suggest 
that routine multi-dose antibiotic prophylaxis regimens could be replaced by a 
single dose regimen. 16
Chan AC et al (1989) in their prospective double blind randomized trial at 
the Dept. of O & G, the Chinese University of Hong Kong involving 4 groups of  
patients receiving a single intravenous dose of placebo, ampicillin, ampicillin and 
metronidazole and amplicillin and sulbactam before operation and showed no 
difference in post-operative morbidity between the 4 groups of patients.  17
11
King C (1989)  in  his  study on the  factors  influencing  the  incidence of 
sepsis following Caesarean section showed that all  Caesars probably warrant 
prophylactic antibiotic. These should be given parenterally in high doses, starting 
perioperatively. Single does have been found effective. Antibiotic prophylaxis for 
caesarean section should be preoperative ensuring a high plasma concentration 
of antibiotic during the operation. 18
Mallaret et  al  (1990) in their study on 266 women who had caesarean 
without  high  risk  of  infection  in  order  to  study  the  efficiency  of  prophylactic 
antibiotics given during the operation.  One group received 1 gm of  cefotetan 
when the cord was being clamped and the other had an injection of placeto.  
Prophylactic  antibiotics  are  proficient  because  they  reduce  post  caesarean 
morbidity due to endometritis, superficial and deep abscesses and septicaemia. 
The length of  hospital stay was significantly reduced in the group that received 
prophylactic antibiotic. 19
Oimitrov  (1990)  showed  that  antibiotic  prophylaxis  was  of  no  clinical 
efficiency is women with low risk caesarean sections. The author recommends 
restraint  in  antibiotic  prophylaxis  of  such  women,  in  whom  postoperative 
infections  inflammatory  complications  are  anyway  rare)  the  frequency  of 
postoperative  infections  complication  was  6.89%  of  women,  who  received 
penicillin for a period of 3 to 5 days but 5.67% of women who did not received 
antibiotics prophylactically. 20
12
Kristensen et  al  (1990)  showed single  dose antibiotic  prophylaxis  after 
cord  clamping  in  patients  undergoing  nonelective  caesarean  sections 
significantly reduced the incidence of febrile morbidity without producing any side 
effect. 21
Howie PW et al (1990) showed the efficiency of prophylactic antibiotics in 
caesarean section. 22
Escobedo Labat etal (1991) compared a long course of ampicillin (7 days) 
to a short course of ampicillin (3 doses) to placebo, 31 patients were included in 
the placebo group and 60 in the drug groups. Only one patient in the placebo 
group and one in the drug group developed infectious morbidity. There was no 
significant  difference (P less  than 0.001)  between  the  placebo and ampicillin  
groups. 23
Ng NK, Sivalingam N (1992) in their study on the value of administering 
prophylactic  antibiotics  in  patients  undergoing  emergency  Caesarean  section 
showed  that  prophylactic  antibiotic  appear  to  be  beneficial  and  consideration 
should be given to make it a routine in all emergency caesarean sections.  24
Sulovic V etal (1994) studied the effectiveness of prophylactic ceftriaxone 
in the prevention of complication after caesarean section and its influence on the 
new  born.  There  were  lower  incidence  of  complications  associated  with 
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ceftriaxone  use  than  in  patients  with  no  antibiotic  therapy.  The  new born  to 
mothers who received ceftriaxone had high Apgar scores. 25
Wax JR etal  (1997) showed that 1gm Cefazolin iv preoperatively is no 
more  effective  than  the  same  dose  administered  after  cord  clamping  in 
preventing post caesarean infectious morbidity such as wound infection, urinary 
tract infection. 26
Huam SH et al (1997) evaluated the effectiveness of single dose antibiotic 
prophylaxis in decreasing the infectious morbidity. A single dose of prophylactic 
antibiotic  significantly  reduced  the  post  operative  morbidity  and  duration  of 
hospital stay in women who underwent elective Caesarean section in their trail.  27
Yip SK etal (1997) studied the effect of single dose prophylactic antibiotic 
on  patients  undergoing  caesarean  section.  Their  trail  showed  single  dose 
prophylactic Augmentation did not produce any clinically significant improvement 
in the postoperative course of patients undergoing caesarean section. If proper 
surgical  techniques  are  followed  in  association  with  closed  rectus  sheath 
drainage, it is unlikely that any trial of antibiotics will be able to demonstrate any  
clinically significant outcome. 28
Kolben  M  etal  (2001)  showed  that  postoperative  infectious  morbidity 
following  low-risk  elective  caesarean  section  cannot  be  reduced  by  intra 
operative antibiotic prophylaxis. 29
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Bagratee et al (2001) showed that antibiotic prophylaxis with cefoxitin in 
elective caesarean section did not reduce post operative infectious morbidity.  30
Bracero  LA 1997 compared single  intravenous dose of  combination of 
ampicillin / scilbactam was as safe and effective as a single intravenous dose of 
Cefotetan  administered  for  the  prevention  of  infections  following  caesarean 
delivery  in  patients  at  high  risk  of  developing  postoperative  morbidity.  Both 
antibiotics were safe and well tolerated with no unusual or unexpected events.  31
Infections occurring after  surgery in  the female reproductive  tract  arise 
from the introduction of normal vaginal flora into the surgical field. More recently,  
short term (24 hrs) or single dose broad spectrum antibiotic have proved to be 
equally  effective.  Therefore  we  recommend  administering  a  broad  spectrum 
antibiotic with a particular sensitivity to gram – ve organisms to inhibit the growth  
of  aerobic  and  anerobic  organisms.  This  should  be given  either  as  an early 
intraoperative single dose (or) as preoperative, intraoperative and postoperative 
doses at 6 hrs intervals. 32
In 1973, Ledger sweet, Heedington were among the first to demonstrate 
the effectiveness of short term prophylactic antibiotic therapy. The human skin is 
constantly  and  continuously  bombarded  by  organisms  present  on  the 
environment,  cultures  from  the  skin  have  demonstrated  diptheroides, 
staphylococcus (Aerobic and anaerobic), gram +ve aerobic spore forming bacilli, 
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strep.  Viridans,  strep.  Faecalis,  gram  neg  bacilli,  E.Coli,  proteus,  candida 
albicans, mycococci, pityrosporum ovale.
The choice of an appropriate prophylactic antibiotics on any grounds other 
than chance is impossible. Where the organism may have varying sensitivity to 
the commonly employed antibiotics. 33
METHODS FOR PREVENTING INFECTION
As  the  old  adage  goes,  prevention  is  better  than  cure,  certain  basic 
principles will hold good as to the obstetrician’s role in preventing post operative 
infection.
PREOPERATIVE PREPARATION
Certain simple practices may go a long way for better results.
Identification  of  high  risk  patients  antenatally  and  correction  of  any 
preventable  factor  (eg.  Building  up the  hemoglobin  of  anemic  patients,  good 
glycemic control in diabetic patients, treatment of pre-existing infection).
Care in labour (where Trial  of vaginal delivery is being given) to avoid 
repeated pervaginal examination and judicious amniotomy (once the membranes 
are ruptured, ideally the labour should not last more than 12 hours.
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Shaving of the abdominal hair is now a debated topic as microscopic cuts 
can fester bacteria. It is believed that removal of excess body hair best done on 
table just preoperatively, if possible (or) by clipping.
Preparation of the operative area should be meticulously done, using a 
suitable antiseptic solution, spirit and an iodine based paint. 32
INTRAOPERATIVE CARE
It has often been claimed that the origin of the most of the postoperative 
problems is at the time of surgery itself. The ways to reduce problems include.
Use of isolation towels especially for potentially infected / High risk cases.
Meticulous hemostasis as blood clots acts as a nidus to fester bacteria.
Adherance to surgical principles of minimizing tissue trauma and avoiding 
crushing / over cauterizing the tissues.
Careful suctioning of all collected fluid, (blood amniotic fluid, meconium) 
from the abdominal cavity with peritoneal lavage as necessary.
Exteriorization of the uterus (eventration) to facilitate suturing is a common 
practice but controversial now. It is claimed that such a practice may predispose 
to tissue trauma to adnexa and to infection.Use of suture material which causes 
less tissue reaction is claimed to have better results as for as healing goes.
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If subcuticular closure of skin is practiced, ensuring complete hemostasis 
is  essential,  along with  use of  a  less reactive  suture material.  In  all  cases a 
nonbraided  or  monofilament,  suture  is  considered  preferable  as  polyfilament 
materials act as wicks, drawing bacteria inside them. 33
POST-OPERATIVE SEPSIS
Antibiotic  prophylaxis  has  had  a  major  beneficial  effect  on  infectious 
morbidity  postcaesarean  and  posthysterectomy  as  confirmed  by  Cochrane 
overviews of 69 randomised controlled trails of antibiotics given at the time of  
caesarean  section.  They  have  unequivocally  demonstrated  that  there  is 
statistically  significant  reduction  on  postpartum febrile  morbidity,  endometritis, 
wound  infection  and  serious  infections.  Routine  antibiotics  can  also  cause 
widespread  resistance  like  methicillin  resistant  staph  aureus.  Preventing 
infections  at  operative  sites  has  long  been  a  goal  of  gynaecological  and 
obstetrical surgeons. These infections constitute leading cause of morbidity after 
both  elective  and  emergency  surgical  procedures  and  can  cause  serious 
sequelae like phlegmon, pelvic abscesses, septic pelvic thrombophlebitis, wound 
abscess and wound dehiscence.
POST-OPERATIVE SEPSIS
Complications after caesarean section
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1) Urinary Tract Infection (UTI) :
UTI are common problems post caesarean and post hysterectomy with 
reported  rates  of  bacteremia  of  20%  post  catheterization.  Symptoms  are 
frequency and burning micturition with lower abdominal pain and fever. Although 
catheterization is relatively safe in an office setting, numerous bladder infections 
are caused in hospitalized patients when urethral organisms are introduced via 
this common procedure.
Most  UTI’s  are  caused  by  gram  negative  bacilli.  Up  to  10  percent, 
however,  may be caused by gram positive organism commonly enterococcus 
infection due to anaerobic organisms is extremely rare. Whereas chlamydial and 
mycoplasmal infections are increasing. The gram negative bacilli that cause over 
60  percent  of  UTI’s  are Escherichia  coli,  followed in  frequency by Klebsiella, 
enterobacter, proteus, providencia  and pseudomonas. Occasionally serratia and 
other bacteria isolated. Diagonosis is confirmed by urine culture and treatment 
depends on culture sensitivity.  Amoxycilin, coamoxclav, ciprofloxacin are good 
urinary antiseptics which will take care of wound infection also.
Wound Sepsis :
Wound infection can complicate upto 20-27% caesarean section. The rate 
of wound sepsis are different on different categories of surgeries and were 7% 
and 30% primary obstetrical and repeat obstetric surgeries respectively. High risk 
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factors for wound sepsis are obesity, difficult and prolonged surgery, membranes 
ruptured more than 12 hrs and more than 7 vaginal examinations.
Treatment included broadspectrum antibiotics and drainage of pus from 
wound by removing stitches.
Respiratory Tract infections
They can occur on any patient including postoperative cases, more so in 
patients who had general anaesthesia for the surgery. Symptoms will be cough 
with expectoration, fever,  treatment is by amoxicillin or cephalosporins, steam 
inhalation and cough suppressants.
Malaria :
In  India,  Malaria  can occur  in  postoperative  period  due to  mosquitoes 
producing  high  grade  intermittent  fever  with  rigor  and  chills.  Diagnosis  is  by 
peripheral blood film for malarial parasites and treatment is with chloroquine or 
other antimalarial agents
Genital Infection :
Genital infection can occur in obstetric and gynecological surgery and can 
be  cuffs  cellulitis  and  pelvic  inflammatory  disease  or  pelvic  cellulitis  and 
parametritis and abscesses.
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Complications of Uterine Infection
After Caesarean Section majority of patients (upto 90%) respond within 
48-72hours with antibiotics but few can have following complications.
Peritonitis
It  is  a serious complication and can happen by lymphatic  spread from 
uterine infection or from uterine incisional necrosis and dehiscence. Even rupture 
of  pelvic  cellulitis  or  parametrial  and  adnexal  abscess  can  cause  peritonitis. 
Patient will be very sick with high grade fever, severe abdominal pain, marked 
bowel  distention.  Treatment  is  by  combination  of  antimicrobial  therapy  and 
surgical drainage of pus if localization of pus occurs. Intra venous hydration is 
required.  Remote  complications  will  be  adhesion  formation  causing  intestinal 
obstruction.
Adnexal Infection
Tubal and ovarian abscess can be formed which may rupture to cause 
peritonitis  or  causes  tubal  blockade  and  infertility.  Antimicrobial  therapy  and 
surgical drainage if localized abscess may be required.
Parametrial Phlegmon
It is a type of parametrial cellulitis causing induration in broad ligaments 
and  can  extend  into  uterine  incision  causing  necrosis.  Treatment  is  by 
antimicrobial  therapy,  routine  hydration  and sometimes  subtotal  hysterectomy 
with removal of mass if possible.
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Pelvic Abscess
It  may be a complication  of  puerperal  sepsis  or  parametrial  phlegmon 
forming a fluctuant swelling in the pouch of Douglas which if left untreated can 
rupture  and  cause  generalised  peritonitis.  Treatment  is  drainage  of  abscess 
usually  by  colpotomy  and  leaving  a  drain  and  broad  spectrum  antimicrobial 
therapy.
Antibiotic  prophylaxis  has  had  major  beneficial  effect  on  infectious 
morbidity post caesarean as confirmed by Cochrane overviews of 69 randomized 
controlled trails of antibiotics given at the time of caesarean operation. There can 
be abdominal incisional infection following caesarean in 3-15% cases which can 
be  reduced  to  2%  by  prophylactic  antibiotics.  They  have  unequivocally 
demonstrated  that  there  is  a  statistically  significant  reduction  in  postpartum 
febrile morbidity. Endometritis, wound infection and serious infections.
CEPHALOSPORINS
History and Source 
Cephalosporium acremonium, the first source of the cephalosporins, was 
isolated in 1948 by Brotzu from the sea near a sewer outlet off the Sardinian 
coast. Crude filtrates from cultures of this fungus were found to inhibit the in vitro 
growth of staph aureus and to cure staphylococcal infections and typhoid fever in 
human beings. Culture fluids in which the Sardinian fungus was cultivated were 
found to contain three distinct antibiotics, which were named cephalosporin P, N, 
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and  C.  With  the  isolation  of  the  active  nucleus  of  cephalosporin  C,  7-
aminocephalosporinic  acid,  and  with  the  addition  of  side  chains  it  became 
possible  to  produce  semisynthetic  compounds  with  antibacterial  activity  very 
much greater  than that  of  the parent  substance.  (For  a  historical  review and 
discussion  of  the  biochemistry  of  the  cephalosporins,  Abraham,  1962;  Flynn, 
1972).
Chemistry
Cephalosporin C contains a side chain derived from d-a aminiadipic acid,  
which  is  condensed  with  a  dihydrothiazine  b-lactam  ring  system  (7-
aminocephalosporanic  acid).  Compounds  containing  7-aminocephalosporanic 
acid  are  relatively  stable  in  dilute  acid  and  highly  resistant  to  penicillinase, 
regardless of the nature of their side chains and their affinity for the enzyme.
Cephalsoporin C can be hydrolyzed by acid to 7 – aminocephalosporanic 
acid. This compound subsequently has been modified by the addition of different 
side chains to create a whole family of cephalosporin antibiotics. It appears that 
modifications at position 7 of the b-lactam ring are associated with alteration in 
antibacterial activity and that substitutions at position 3 of the dihydrothiazine ring 
are  associated  with  change  in  the  metabolism  and  the  pharmacokinetic 
properties of the drugs (Huber et al 1972).
23
The cephamycins are similar to the cephalosporins, but have a methoxy 
group  at  position  7  of  the  b-lactam ring  of  the  7-aminocephalosporanic  acid 
nucleus.
Mechanism of Action
Cephalosporins and cephamycins inhibits bacterial cell-wall synthesis in a 
manner similar to that of pencillin.
Classification
The explosive growth of the cephalosporins during the past decade has 
taxed the best of memories and makes a system of classification most desirable. 
Although cephalosporins may be classified by their chemical structure, clinical 
pharmacology,  resistance to  β-lactamase,  or antimicrobial  spectrum, the well-
accepted  system  of  classification  by  “generations”  is  very  useful,  although 
admittedly somewhat arbitrary.
Classification by generations is based on general features of antimicrobial 
activity  (Karchmer,  2000).  The first  generation  cephalosporins,  epitomized by 
cephalothin and cefazolin, have good activity against gram positive bacteria and 
relatively modest activity against gram negative microorganisms. Most oral cavity 
anaerobes  are  sensitive,  but  the  B.  fragilis  group  is  resistant.  The  second 
generation  cephalosporins  have  somewhat  increased  activity  against  gram 
negative  microorganisms,  but  are  much  less  active  than the  third  generation 
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agents.  Third  generation  cephalosporins  are  more  active  against  the 




Examples Useful Spectrum 
First Cefazolin  (Ancef,  Kefzol,  Zolicef) 
Cephalothin (Keflin)
Cephalexin (Keflex, cefanex, others)
Streptococci; Stapylococcus aureus.
No  activity  against  Entercocci  or 
Listeria.




Escherichia coli, Klebsiella, proteus, 
Haemophilus  influenzae,  Moraxella 
catarrhalis,  Not  as  active  against 
gram  postive  organisms  as  first 
geneation agents.
Similar  spectrum to  cefuroxime but 




Ceftazidime  (Ceptaz,  Fortaz, 
Tazidime, Others)
Enterobacteriaceae ;
Pseudomonas aeruginosa ; Serratia; 
Neisseria  gonorrhoea;  activity  for 
staphylococcus  aureus  and 
streptococcus  pyogenes, 
comparable  to  first  generation 
agents.
Fourth Cefepime Comparable  to  third  generation  but 
more resistant  to  some         β-
lactamases
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Mechanisms of Bacterial Resistance to the Cephalosporins.
Resistance  to  the  cephalosporins  may  be  related  to  inability  of  the 
antibiotic  to  reach  its  site  of  actions,  to  alterations  in  the  penicillin-binding 
proteins (PBPs) that are targets of the cephalosporins, such that the antibiotics 
bind  with  lower  affinity,  or  to  bacterial  enzymes  (β-lactamases)  that  can 
hydrolyze the β-lactam ring and inactivate the cephalosporin. Alternation in two 
PBPs (1A and 2X), such that they bind cephalosporins with lower affinity,  are 
sufficient to render pneumococcus resistant to third generation cephalosporins, 
as  the  other  three  high  molecular  weight  PBPs  have  inherently  low  affinity 
(Spratt, 1994).
The  most  prevalent  mechanism  of  resistance  to  cephalosprons  in 
destruction of the cephalosporins by hydrolysis of the β-lactam ring. Many gram 
positive microorganisms release relatively large amounts of β-lactamase into the 
surrounding medium. Although gram negative bacteria seem to produce less β-
lactam, the location of their enzyme in the periplasmic space may make it more 
effective in destroying cephalosporins as they diffuse to their targets on the inner 
membrance,  as  in  the  case for  the  penicillins.  The cephalosporins,  however,  
have variable susceptibility to β-lactamase.  The third generation cephalosporins 
are  more  resistant  to  hydrolysis  by  the  β-lactamases.  Induction  of  type  I  – 
lactamases  by  treatment  of  infections  due  to  aerobic  gram  negative  bacilli  
(especially  enterobacter  spp.,  citrobacter  freundii,  Morganella,  Serratia, 
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Providencia,  and  pseud.  Aeruginosa)  with  second  or  third  generation 
cephalosporins and / or imipenem may result in resistance to all third generation 
cephalosporins.
Cephalexin,  cepharadine,  cefaclor,  cefadroxil,  loracarbef,  cefprozil, 
cefixime,  cefpodoxime proxetil,  ceftibuten and cefuroxime axetil  are absorbed 
after  oral  administration  and  can  be  given  by  this  route.  Cephalothin  and 
cephapirin cause pain when given by intramuscular injection and thus are usually 
used only intravenously.  The third generation cephalosporin ceftriaxone canbe 
administered intramuscularly or intravenously.
Cephalosporins are excreted primarily by the kidney, dosage thus should 
be  altered  in  patients  with  renal  insufficiency.  Probenecid  slows  the  tubular 
secretion of most cephalosporins (DeSante et al 1982).
Several cephalosporins penetrate into CSF in sufficient concentration to 
be useful for the treatment of meningitis. These include cefuroxime, moxalactam, 
cefotaxime,  ceftriaxone,  cefepime,  and  ceftizoxime  (Therapeutic  Uses). 
Cephalosporins  also  cross  the  placenta,  and  they  are  found  in  high 
concentrations  in  synovial  and  pericardial  fluid.  Penetration  into  the  aqueous 
humor  of  the  eye  is  relatively  good  after  systemic  administration  of  third 
generation agents, but penetration into the vitreous humor is poor. There is some 
evidence that concentrations sufficient for therapy of ocular infection due to gram 
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positive  and  certain  gram  negative  microorganisms  can  be  achieved  after 
systemic administration.
Third Generation Cephalosporins
Structural formula of Ceftriaxone (Rochephin)
T1-2= 8 hours
Third generation cephalosporin with good activity against pseudomonas.
Cefotaxime was the first of the third generation cephalosporins to become 
available on the United States.  Ceftriaxone is highly resistant  to many of the 
bacterial  β-lactamases and has good activity against many gram positive and 
gram negative aerobic bacteria. However, activity against B. Fragilis is poor as 
compared to agents such as clindamycin and metronidazole (Neu et al 1979). 
Ceftriaxone has half life in plasma of about 8 hours and administration of the 
drug  every   12  hours  for  serious  infections.  Cerftriaxone  has  been  utilized 
effectively  for  meningitis  caused  by  H.  influenzae,  penicillin  sensitive  strep. 
Pneumoniae and N. meningitides (Landesman et al 1981, Cherubin et al 1982, 
Mullaney  and  John  1983).  Cerftriaxone  has  a  half  life  of  about  8  hrs. 
Administration of the drug once or twice daily been effective for meningitis. (Del 
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Rio et al.,1983; Brogden and ward, 1988), whereas dosage once a day has been 
effective for other infection (Baumgartner and Glauser, 1983). About half the drug 
can be recovered from the urine. The remainder appears to be eliminated by 
biliary secretion. A single dose of Cerftriaxone (125 to 250 mgs) is effective in the 
treatment of urethral, cervical, rectal or pharyngeal gonorrhea, including disease 
caused by penicillinase producing microorganisms.
ADVERSE REACTIONS
Hypersensitivity  reactions to  the  cephalosporins  are  the  most  common 
side effects (Pets, 1978), and there is no evidence that any single cephalosporin 
is more or less likely to cause such sensitization. The reactions appear to be 
identical to those caused by the penicillins, and this may be related to the shared 
β-lactam structure of both groups of antibiotics (Bennett et al., 1983). Immediate 
reactions such as anaphylaxis bronchospasm, and urticaria are observed. More 
commonly, maculopapular rash develops, usually after several days of therapy ;  
this may not be accompanied by fever and eosinophilia.
Because of the similarity in structure of the penicillins and cephalosporins, 
patients who are allergic to one class of agents may manifest cross-reactivity 
when a member of the other class is administered. Immunological studies have 
demonstrated  cross-reactivity  in  as  many  as  20% of  patients  a  much  lower 
frequency (about 1%) of such reactions (Saxon et al., 1984). There are no skin 
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tests that can reliably predict whether a patient will manifest an allergic reaction 
to the cephalosporins.
Patients with a history of a mild or a temporally distant reaction to penicillin 
appear  to  be  at  low  risk  of  rash  or  other  allergic  reaction  following  the 
administration  of  a  cephalosporin.  However,  patients  who  have had a  recent 
severe, immediate reaction to a penicillin should be given a cephalosporin with 
great caution, if at all. A positive Coomb’s reaction appears frequently in patients 
who receive large doses of a cephalosporins have produced rare instances of 
bone-marrow depression, characterized by granulocytopenia (Kammer, 1984).
The  cephalosporins  have  been  implicated  as  potentially  nephrotoxic 
agents,  although  they  are  not  nearly  as  toxic  to  the  kidney  as  are  the 
aminoglycosides or the polymyxins (Barza, 1978).  Renal  tubular necrosis has 
followed the administration of cephaloridine in doses greater than 4 g per day ; 
this agent is no longer available in the United States. Cephalosporins are much 
less toxic and, in recommended doses, rarely produce significant renal toxicity 
when  used  by  themselves.  High  doses  of  cephalothin  have  produced  acute 
tubular necrosis in certain instances, and usual doses (8 to 12g per day) have 
caused nephrotoxicity in patients with preexisting renal disease (Pasternack and 
Stepens,  1975).  Serious  bleeding  related  either  to  hypoprothombinemia, 
thrombocytopenia and / or platelet dysfunction has been reported with several β-
lactam antibiotics (Bank and Kammer, 1983; Sattler et al., 1986.
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THERAPEUTIC USES
The  cephalosporins  are  widely  used  and  therapeutically  important 
antibiotics. Clinical studies have shown cephalosporins to be effective as both 
therapeutic  and  prophylactic  agents  (Donowitz  and  Mandell,  1988). 
Cephalosporins, either with or without aminoglycosides, have been considered to 
be the drugs of choice for serious infections caused by Klebsiella, Enterobacter, 
Proteus, Providencia, Serratia, and Haemophilus species. The third-generation 
cephalosporins cefotaxime or ceftriaxone currently are the drugs of choice for the 
initial treatment of meningitis in nonimmunocompromised adults, children older 
than 3 months (pending identification of the causative agent) because of their 
antimicrobial activity, good penetration into CSF, and record of clinical success. 
They are of proven effectiveness for the treatment of meningitis caused by H. 
influenzae,  sensitive  Strp.  Penumoniae,  N.  Meningitidis,  and  gram-negative 
enteric bacteria.
Cephalosporins still are useful as alternatives to penicillins for a variety of 
infections in patients who cannot tolerate penicillins. These include streptococcal 
and straphylococcal infections. Infections with anaerobes often are treated with 
combinations  of  antibiotics,  since  aerobic  microorganisms  usually  also  are 
present.
The  spectrum  of  activity  of  cefuroxime,  cefotaxime,  ceftriaxone,  and 
ceftizoxime appears to be excellent for the treatment of pneumonias acquired in 
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the  community.  ie.,  those  caused  by  pneumococci  (except  cephalosporin 
resistant isolates) H.influenzae (including strains that produce  β-lactamase) or 
staphylococci.
Nosocomial infections frequently are caused by microorganisms that are 
resistant  to  many  of  the  commonly  used  agents,  such  as  many  of  the 
cephalosporins,  ampicillin  and  some  of  the  antipseudomonal  penicillins  and 
aminoglycosides.  Third  generation  cephalosporins  and  imipenem  have  been 
useful  additions  to  therapy,  but  the  emergence  of  inducible  chromosomal  β-
lactacmases  and  plasmid  mediated,  extended  spectrum  β-lactamases  in 
nosocomial, enteric, gram negative bacilli has limited their usefulness. Patients 
who are severely neutropenic have been treated successfully with either a third 
generation cephalosporin plus an aminoglycoside or for selected patients a third 
generation cephalosporin that is active against Pseudomonas (e.g. ceftazidime) 
without an aminoglycoside (Pizzo et al. 1986)
32
MATERIALS AND METHODS OF STUDY
The  study  was  carried  out  in  the  Department  of  Obstetrics  and 
Gynaecology, Government RSRM Hospital, Chennai. The period of study from 
June  2007 to October 2008.
This  was  a  prospective  study  which  involved  1000  cases  who  were 
divided into two groups randomly after excluding the exclusion criteria. 
The Exclusion Criteria were:-
1) Hypersensitivity to Cephalosporins
2) Preexisting infection 
3) Concomitant  systemic  disease  such  as  uncontrolled  diabetes, 
hypertension, renal or hepatic disease 
4) PROM
5) Patients on pretreatment with other antibiotics.
6) Patients  with  Asthma,  Anemia,  Temperature  >380C,  respiratory 
insufficiency or those having any sort of infection not included in the study.
Group I consisted of 500 Cases who were given Inj. Ceftriaxone 1gm IV at 
the time of clamping of the umbilical cord during caesarean section.
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Group – II consisted of 500 cases who received Inj. Ampicillin 500mgs and 
Inj. Garamycin 80mgs which was started 4-6hrs after surgery and was given bd 
for 48hrs followed by oral amoxicillin 500mgs 6hrly for 72 hours and gentamycin 
80mgs Im 12 hourly for 5 days.
The presence of  temperature,  vaginal  infection,  Urinary Tract  Infection, 
Respiratory  Tract  Infection,  abdominal  wound  infection,  need  for  additional 
antibiotic and the period of hospital stay were carefully noted. High vaginal swab 
and abdominal wound swab were sent for culture and sensitivity and results on 
each group were meticulously compared.
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RESULTS
Total No. of Cases taken for Group – I : 500
Total No. of Cases taken for Group – II : 500
AGE DISTRIBUTION IN LSCS GROUP
TABLE – I
Age Group Group – I Group – IINo % No %
16-25 Years 435 87% 422 84.4%
26-30 Years 57 11.4% 67 13.4%
31 & above 8 1.6% 11 2.2%
Table – 1: Shows the Age Distribution in both LSCS Group – I & II.
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Group – I Group – II
No % No %
Primi 232 46.4% 243 48.6%
Multi 268 53.6% 257 51.4%















Group – I Group – II
No % No %
Elective LSCS 5 1% 6 1.2%
Emergency LSCS 301 60.2% 324 64.8%
Repeat LSCS 194 38.8% 170 34.0%
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Indication Group – I Group – IINo % No %
Previous LSCS 
with CPD
197 39.4 166 33.2
Fetal Distress 81 16.2 83 16.6
Failed Induction 28 5.6 44 8.8
Breech 32 6.4 34 6.8
CPD 53 10.6 54 10.8
Oligohydramnios 24 4.8 17 3.4
Mal Presentation 2 0.4 2 0.4
BOH 11 2.2 7 1.4
Others 72 14.4 93 18.6








































GE Group - I
Group - II
BLOOD LOSS DURING LSCS
TABLE – 5
Blood Loss Group – I Group – IINo % No %
500 – 750ml 300 60 360 72
750 – 1000ml 200 40 140 28
> 1000ml - - - -
Table – 5: shows the amount of Blood Loss during LSCS in both             Group –  
I & II.
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Group – I Group – II
No % No %
Temperature 20 4 51 10.2
Cough 4 0.8 10 2
Vomiting 20 4
Abdominal Distension 10 2
Wound Infection 9 1.8 41 8.2
UTI 10 2 33 6.6
Adverse Reactions 10 2
Abdominal Wound Resuturing 5 1
Thromphlebitis
Table – 6: shows the Post Operative Complications of 1000 patients undergone 
















Organisms Cultured Group – I Group - II
E-coli - 9
Staphylococcus Aureus 10 30
Klebsiella - 2
Proteus - -
Table – 7: shows the Wound Infection in Group- I & II.
URINARY  TRACT INFECTION
TABLE – 8
Organisms Cultured Group – I Group - II
E-coli 10 28
Staphylococcus Aureus - -
Klebsiella - 4
Proteus - 1
Table – 8: shows the Urinary Tract Infection in Group- I & II.
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INFECTIOUS  MORBIDITY 
TABLE – 9
Results Group – I Group - II P-Value
Febrile Morbidity 4% 10.2% <0.001
Wound Infection 1.8% 8.2% <0.001
Urinary Tract Infection 2% 6.6% <0.001
Abnormal Vaginal Discharge - 2% Not 
Significant
Table – 9: shows the Infectious Morbidity in Group I & II.
POST OPERATIVE PERIOD
TABLE – 10
Post – Op Period No. of Days of Hospital 
Stay
Group – I Group - II
Afebrile Patients 9 9
Febrile Patients 12 15
Wound Infection 14 16
UTI 10 12
    Table 10 shows postoperative period in both groups. Over all mean post 
operative  hospital  stay  for  all  patients  in  the  ceftriaxone  group  was 
significantly less than that of control group.
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DISCUSSION
The primary aim of prophylactic antibiotics is to reduce the infection and 
thereby  reduce  morbidity  and  mortality.  Antibiotic  prophylaxis  for  caesarean 
section  should  be  perioperative,  ensuring  a  high  plasma  concentration  of 
antibiotic during the operation. Various recent studies in obstetric cases proved 
that there is definite role of  prophylactic  antibiotics (Huam et al  1997  27   and 
Sulovic V et al 1994 25, bagratee 200130). 
Before the routine use of prophylactic antibiotics for caesarean section, 
the febrile morbidity and endomyometritis rates were 36% and 32% respectively.  




Group – I Group – II
Kristenesen 1990 2% 19.2%
Saltzman 1985 14% 32.7%
Itskovitz J 1979 16% 30%
Huam 1997 8% 18%
Bagratee 2001 8.3% 7.9%
Mancuso 1989 8% 9.6%
Sulovic 1994 12.5 24.2
Study Group 4% 10.2%
In the present study, the febrile morbidity was 4% in the ceftriaxone group 
when compared to 10.2% in the conventional agents in Group – II.
In Group – I, 20 patients developed fever, these patients had low grade 
temperature which lasted for 3 days. 9 Patients had abdominal wound infection 
and  the  culture  showed  growth  of  staphylococcus  aureus  sensitive  to 
ciprofloxacin. 
In Group – II, 55 Patients developed fever. These patients had low grade 
temperature which lasted for 3 days.   5 Patients had high grade temperature 
1010 F  lasted  for  2  days.  Blood  Smear  for  malaria  taken  and  treated  with  
Chloroquine.  41 patients had abdominal wound infection and the culture showed 
growth of Staphylococcus aureus sensitive to Ciprofloxacin. In 2 patients wound 




WOUND  INFECTION 
Group – I Group – II
Huam 1997 3% 13%
Bagratee 2001 12.5% 13.3%
Mallaret 1990 12.5% 26%
M.K. Swamy 1998 4% 16%
Brar et al 1999 8% 28%
Study Group 1.8% 8.2%
Table 2 shows the wound infection rate in various studies.
In Group – I, 9 patients developed wound infection, 6 patients on 6 th post 
operative days and 4 on 7th post operative day and culture showed growth of 
staphylococcus aureus sensitive to ciprofloxacin.
In  Group – 2,  41  patients  developed wound  infection.  19 patients  had 
growth of staphylococcus aureus sensitive to ciprofloxacin, 4 patient had E.coli 
and other patient had klebsiella sensitive to Norfloxacin.
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TABLE – 3
URINARY  TRACT INFECTION
Group – I Group – II
Agarwal 1993 Nil 6%
Batra 1994 4% 8%
M.K. Swamy 1998 2% 22%
Brar et al 1999 12% 32%
Study Group 2% 6.6%
Table 3 shows the Urinary Tract Infection in various studies. In the present 
study UTI was 2% in the ceftriaxone group and 6.6% in the use of conventional  
agents. 
In Group – 1, 10 patients developed UTI on 5 th post operative day. These 
patients had growth of E.Coli sensitive to norfloxacin.
In  Group – II,  33  patients  had UTI.  These patients  developed burning 
micturition  on  6th post  operative  day,  25  patients  had  E.coli  sensitive  to 





Group – I Group – II
Batra 1994 Nil 4%
Brar et al 1999 Nil 8%
Samal 1988 2% 2%
M.K. Swamy 1998 1% 15%
Study Group Nil 2%
In Group – II, 10 patients had diarrhea for 2 days. In these cases ampicillin 
was omitted and ciprofloxacin started.
Extended  courses  can  be  kept  for  cases  requiring  prolonged  surgical 
procedures.
In the present study, single dose use of ceftriaxone has been documented to 
be more effective in controlling tissue inflammatory response as compared to 
traditional use of extended two drugs combination Ampicillin and Gentamycin.
Ceftriaxone  is  well  tolerated  after  IV  injection.  They  also  have  added 
advantage of safety and tolerance. Lower infection rates can be achieved using 
long acting antibiotic such as ceftriaxone given as a single dose 1gm30.
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SUMMARY
1. 500 cases of LSCS were included in Group – I and these were given Inj. 
Ceftriaxone 1gm IV at the time of  clamping umbilical cord.
2. 500 Cases of LSCS were included in Group – II and they were given Inj. 
Ampicillin 500mgs 12 hourly and Inj. Garamycin 80mgs 12 hourly for 5 days 
as in the present practice.
3. Incidence  of  febrile  morbidity  in  Ceftriaxone  Group  was  4%  and  in 
Ampicillin / Garamycin Group was 10.2% with P Value of <0.001
4. Incidence  of  wound  infection  in  Ceftriaxone  Group  was  1.8%  and  in 
Ampicillin / Garamycin Group was 8.2% with P-Value of <0.001
5. Culture  and  sensitivity  of  pus  from  wound  shows  the  growth  of 
staphylococcus  aureus  in  Ceftriaxone  Group  was  1.8% and  Ampicillin  / 
Garamycin  Group  was  8.2%.  In  Group-II  in  addition  to  staphylococcus, 
organisms grown were E.coli and Klebsiella and appropriate antibiotic like 
norfloxacin were started.
6. Incidence  of  urinary  tract  infections  in  Ceftriaxone  Group   was  2% and 
Ampicillin/Garamycin Group was 6.6% and the organisms responsible for 
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UTI were E.coli in Group –I. In Group II E.coli, Klebsiella and proteus and 
appropriate antibiotics like ciprofloxacin started.
7. Incidence  of  adverse  reactions  were  nil  in  Ceftriaxone  Group   and  in 
Ampicillin /Garamycin Group were 2%.
8. Overall  mean  postoperative  hospital  stay  was  significantly  less  in 
Ceftriaxone Group than Ampicillin/Garamycin Group. 
9.  Single dose Ceftriaxone prophylaxis  is cost  effective in  that  the cost  of 
treatment  is  4  times less than that  of  conventional  antibiotic  Ampicillin  /  
Garamycin. 
10. Ceftriaxone prophylaxis is safe, effective, convenient and saves manpower 
thus preventing irregularity in administering drugs and can easily replace the 
5 days extended use of antibiotics.
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CONCLUSION
In  the present  study antibiotic  prophylaxis  with  single  dose ceftriaxone 
1gm iv administered at the time of cord clamping in caesarean section is very 
safe,  cost  effective,  more  convenient  and also  effective  in  reducing  maternal 
morbidity and post operative hospital stay when compared to traditional use of 
Ampicillin / Garamycin in caesarean section.  
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PROFORMA
LSCS GROUP - I
Name : Age  :                I.P.No.    : 
Address:      Ht            :
     Wt            :
G P L A LMP EDD
Marital H/o DOA :
Menstrual H/o DOS :
Past H/o DOD :
Obstetric H/o
Present Pregnancy
Admission for complaints Pain / Safe Confinement
GENERAL EXAMINATION 
CVS : Pulse : Temp :
RS : RR : BP :
P/A Uterine Ht : Estimated Fetal Wt :
Lie : Type of Incision :
Presentation : Head: Mobile / Unengated




Hb% Bl. Group :
Urine : Alb USG :
Sug.
Dep Bl. Sugar :
Indication for Surgery :
Duration of Surgery :
Antibiotics :
Blood Transfusion : Yes . No Anaesthesia:
Post Operative Period :











Condition at the time of discharge:
62








Surgery Indication Wound UTI Fever Adverse Abnormal Organisms Other
N
o Infection Reactions Vaginal Cultured Antibiotic
Dischar
ge Used
1 Navarathana 659 26F G2 P1 L0 Em. LSCS Foetal alarm sign Nil
Ni
l Nil Nil Nil Nil Nil
2 Manjula 757 19F
G3 P1 L0 
A1 Em. LSCS BOH failure to Progress Nil
Ni
l Nil Nil Nil Nil Nil
3 Bagiyamma 685 24F
G3 P1 L1 
A1 Em. Rpt LSCS Prev LSCS with UE head Nil
Ni
l Nil Nil Nil Nil Nil
4 Ambaligai 197 28F Primi EM. LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
5 Stellamary 986 24F
G4 P1 L1 
A2 Em. LSCS PIH with CPD Nil
Ni
l Nil Nil Nil Nil Nil
6 Selvi
105
4 26F G2 P1 L1 Em. RPT LSCS Prev. LSCS UE head Nil
Ni





6 28F G2 P1 L1 Em. LSCS ST Prev. LSCS in labour Nil
Ni
l Nil Nil Nil Nil Nil
8 Malleswari
108
3 28F G2 P1 L1 Em. Rpt LSCS ST Prev. LSCS with UE head Nil
Ni
l Nil Nil Nil Nil Nil
9 Sumathy
108
2 20F G2 P1 L1 Em. LSCS  ST Prev. LSCS  Nil
Ni
l Nil Nil Nil Nil Nil
10 Saritha
100
2 23F Primi Em. LSCS Post datism Fetal distress Nil
Ni
l Nil Nil Nil Nil Nil
11 Sujatha 732 25F Primi Em. LSCS
Post datism Failed 
induction Nil
Ni
l Nil Nil Nil Nil Nil
12 Kumudha 
102
7 23F G2 P1 L1 Ele Rpt LSCS ST Prev. LSCS Nil
Ni
l Nil Nil Nil Nil Nil
13 Srividhya
770
4 20F Primi Em. LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
14 Shanthi
772
8 18F G2 P1 L1 
Em. Rpt. LSCS 
ST
Prev LSCS with CPD in 
labor Nil
Ni
l Nil Nil Nil Nil Nil
15 Dhanalakshmi
755
9 24F Primi Em. LSCS Short PRIMI with CPD Nil
Ni
l Nil Nil Nil Nil Nil
16 Seetha
712
5 22F G2 P1 L0 Em. LSCS Twin preg with BOH Nil
Ni
l Nil Nil Nil Nil Nil
17 Sujatha
757
0 26F G2 P1 L1 El. Rpt LSCS ST Prev. LSCS Nil
Ni
l Nil Nil Nil Nil Nil
18 Sumathy
771
3 25F Primi Em. LSCS MSAF with FD Nil
Ni
l Nil Nil Nil Nil Nil
19 Saraswathy
757
3 28F G3 P2 L1 Em. Rpt LSCS Prev. LSCS with CPD Nil
Ni
l Nil Nil Nil Nil Nil
20 Fathima
770
1 20F Primi Em.LSCS Oligohydramnios Nil
Ni
l Nil Nil Nil Nil Nil
21 Sridevi
766
1 27F G2 P1 L1 Em. Rpt LSCS
Prev. LSCS  fetal alarm 
sign Nil
Ni
l Nil Nil Nil Nil Nil
22 Sumathy 
755
5 28F Primi Em. LSCS Failure to progress Nil
Ni
l Nil Nil Nil Nil Nil
23 Egavalli
775
8 29F Primi Em. LSCS Long period of infertility Nil
Ni
l Nil Nil Nil Nil Nil
24 Gunasundari
776
8 23F Primi Em. LSCS Breech Nil
Ni
l Nil Nil Nil Nil Nil
25 Selvi
778
0 18F G2 P1 L1
Em. Rpt. LSCS 
ST Prev. LSCS in labour Nil
Ni




2 20F Primi Em. LSCS Breech in labour Nil
Ni




G3 P1 L1 
A1 Em. Rpt. LSCS Prev. LSCS with FD Nil
Ni
l Nil Nil Nil Nil Nil
28 Parveen
778
3 23F G2 P1 L1 Em. Rpt LSCS ST Prev LSCS in labour Nil
Ni
l Nil Nil Nil Nil Nil
29 Selvi
781
8 30F Primi Em. LSCS Ap Ecclampsia Nil
Ni
l Nil Nil Nil Nil Nil
30 Selvi
762
6 32F G3 P2 L1 El. Rpt. LSCS ST Prev LSCS Mobile Head Nil
Ni
l Nil Nil Nil Nil Nil
31 Lakshmi
762
5 22F G2 P1 L1 El. Rpt LSCS ST Prev  LSCS CPD Nil
Ni
l Nil Nil Nil Nil Nil
32 Geetha
766
4 28F G2 P1 L1
Em. Rpt. LSCS 
ST Prev LSCS in labour Nil
Ni
l Nil Nil Nil Nil Nil
33 Jamuna 
779
3 26F Primi Em. LSCS CPD Nil
Ni
l Nil Nil Nil Nil Nil
34 Lakshmi
778
2 25F Primi Em. LSCS CPD in labour Nil
Ni
l Nil Nil Nil Nil Nil
35 Geetha
766
4 28F G2 P1 L1 Em. Rpt LSCS ST Prev. LSCS in labour Nil
Ni
l Nil Nil Nil Nil Nil
36 Jamuna
779





2 25F Primi EM. LSCS CPD in labour Nil
Ni
l Nil Nil Nil Nil Nil
38 Karpagam
775
6 19F Primi Em. LSCS CPD Nil
Ni





Em. Rpt LSCS Prev. LSCS with Oilgo Nil
Ni





Em. Rpt LSCS Prev. LSCS CPD Nil
Ni
l Nil Nil Nil Nil Nil
41 Vijarya
744
3 21F Primi Em. LSCS Breech in labor Nil
Ni
l Nil Nil Nil Nil Nil
42 Mymoon
783
7 23F Primi EM. LSCS Primi with MSAF / FD Nil
Ni
l Nil Nil Nil Nil Nil
43 Mahalakshmi
762
8 22F G2 P1 L1 El. Rpt LSCS Prev. LSCS mobile head Nil
Ni
l Nil Nil Nil Nil Nil
44 Kalai
737
1 24F G2 P1 L1 El. Rpt. LSCS Perv. LSCS UE head Nil
Ni
l Nil Nil Nil Nil Nil
45 Jamuna
776
3 26F G2 P1 L1 Em. Rpt LSCS ST Prev. LSCS UE in labour Nil
Ni
l Nil Nil Nil Nil Nil
46 Latha
778
6 26F Primi Em. LSCS MSAF Nil
Ni





6 22F Primi Em. LSCS Breech Nil
Ni
l Nil Nil Nil Nil Nil
48 Sheerja
789
3 22F G2 P1 L1 Em. Rpt LSCS Prev LSCS with oligo Nil
Ni
l Nil Nil Nil Nil Nil
49 Gayathri
757
7 17F G2 P1 L1 Em. Rpt LSCS Prev. LSCS with CPD Nil
Ni
l Nil Nil Nil Nil Nil
50 Jayanthi
777
5 19F G2 P1 L1 Em. Rpt LSCS ST Prev. LSCS / CPD in labor +
Ni







4 23F Primi Em. LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
52 Parvathy
791
6 19F Primi Em. LSCS Brow Presentation Nil
Ni
l Nil Nil Nil Nil Nil
53 Arivazhagi
792
0 18F G2 P1 L1
Em. LSCS with 
ST Breech Nil
Ni
l Nil Nil Nil Nil Nil
54 Shenbagam
792
7 19F G2 P1 L1
Em. LSCS with 
ST FD Nil
Ni
l Nil Nil Nil Nil Nil
55 Kasthuri
783
9 22F G2 P1 L1 El. Rpt LSCS Prev. LSCS Nil
Ni




2 27F G2 P1 L1
Em. RPt LSCS 
ST Prev. LSCS / PIH Nil
Ni
l Nil Nil Nil Nil Nil
57 Uma
781
3 21F G2 P1 L1 Em. Rpt LSCS Prev. LSCS in labour Nil
Ni
l Nil Nil Nil Nil Nil
58 Ramayee
758
8 23F G2 P1 L1 El. Rpt LSCS Prev. LSCS Nil
Ni





3 22F Primi Em. LSCS Short Primi CPD / PIH Nil
Ni
l Nil Nil Nil Nil Nil
60 Vimala
793
6 20F G2 A1 Em. LSCS Failed Induction Nil
Ni
l Nil Nil Nil Nil Nil
61 Kavitha
778
6 28F Primi Em. LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
62 Devi
797
6 23F G2 P1 L1 Em. LSCS Breech Oligo hydrammios Nil
Ni
l Nil Nil Nil Nil Nil
63 Geetha
793
3 20F G2 A1 Em. LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
64 Sivagami
795
7 24F Primi Em. LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
65 Nalini
783
8 19F G2 P1 L1
Em. LSCS with 
ST Failed induction Nil
Ni
l Nil Nil Nil Nil Nil
66 Indhumathi
798
3 23F Primi Em. LSCS PIH   CPD Nil
Ni
l Nil Nil Nil Nil Nil
67 Malliga
754
8 22F G2 P1 L1 El. Rpt LSCS  ST Prev. LSCS with CPD Nil
Ni
l Nil Nil Nil Nil Nil
68 Usharani
788
0 25F G2 P1 L1 El. Rpt LSCS  ST Prev LSCS Nil
Ni
l Nil Nil Nil Nil Nil
69 Kuppulaxmi
749
9 26F Primi El. LSCS CPD Residual Polio Nil
Ni
l Nil Nil Nil Nil Nil
70 Bagyalakshmi
794
9 22F Primi Em. LSCS
Residual Polio CPD in 
labor Nil
Ni
l Nil Nil Nil Nil Nil
71 Nirmala
755
3 19F G2 P1 L1 Em. Rpt LSCS
Prev LSCS  Multiple 
gestation Nil
Ni
l Nil Nil Nil Nil Nil
72 Geetha
788
9 21F Primi Em. LSCS PIH withCPD Nil
Ni
l Nil Nil Nil Nil Nil
73 Manjula
787
8 23F Primi Em. LSCS Failure to Progress +
Ni







1 24F Primi Em. LSCS CPD MSAF Nil
Ni
l Nil Nil Nil Nil Nil
75 Nagammal
801
0 17F G2 P1 L1 Em. Rpt LSCS Prev. LSCS in labor Nil
Ni
l Nil Nil Nil Nil Nil
76 Kavitha
801
9 23F G2 P1 L1 Emg Rpt LSCS Prev. LSCS in labor Nil
Ni
l Nil Nil Nil Nil Nil
77 Rajeswari
800
8 18F Primi Emg LSCS Breech Nil
Ni
l Nil Nil Nil Nil Nil
78 Sasikala
800
2 18F G2 P1 L1 Emg. Rpt. LSCS Prev. LSCS Nil
Ni
l Nil Nil Nil Nil Nil
79 Jothi
802
9 21F Primi Emg LSCS Breech Nil
Ni
l Nil Nil Nil Nil Nil
80 Sathyakala
803
6 20F G2 P1 L1
Emg.Rpt. LSCS 
ST Prev. LSCS with CPD Nil
Ni
l Nil Nil Nil Nil Nil
81 Sheela Devi
785
2 17F G2 P1 L1
Elect. Rpt LSCS 
ST Prev LSCS Nil
Ni
l Nil Nil Nil Nil Nil
82 Prema
799
9 21F Primi Emg. LSCS PIH / Thick MSAF FD Nil
Ni





Emg. RPT LSCS Prev. LSCS in labor Nil
Ni





Emg. LSCS Prev LSCS in Labour Nil
Ni
l Nil Nil Nil Nil Nil
85 Vasanthi
785
3 24F Primi Emg.   LSCS FD Nil
Ni




2 24F Primi Emg. LSCS CPD with Oligo Nil + + Nil Nil E.coli Norfloxacin
87 Alamma
802
2 18F Primi Emg. LSCS MSAF with FD Nil
Ni
l Nil Nil Nil Nil Nil
88 Vadiu
789
8 22F G2 P1 L1
Emg. Rpt. LSCS 
ST Prev. LSCS in labor Nil
Ni
l Nil Nil Nil Nil Nil
89 Meenatchi
804
1 23F G2 P1 L1 Emg. LSCS Prev. LSCS in labor Nil
Ni
l Nil Nil Nil Nil Nil
90 Vasanthi
785
3 24F Primi Emg  LSCS FD Nil
Ni
l Nil Nil Nil Nil Nil
91 Latha 
797
2 24F Primi Emg LSCS CPD with Oligo H Nil
Ni
l Nil Nil Nil Nil Nil
92 Alamma
802
2 18F Primi Emg. LSCS MSAF with FD Nil
Ni
l Nil Nil Nil Nil Nil
93 Vadivu
789
8 22F G2 P1 L1
Emg. Rpt. LSCS 
ST Prev LSCS in labor Nil
Ni





F Primi Emg.   LSCS Breech Nil
Ni
l Nil Nil Nil Nil Nil
95 Revathy 
805
2 20F Primi Emg LSCS Post dated FD Nil
Ni
l Nil Nil Nil Nil Nil
96 Manjula
805
3 22F G2 P1 L1
Emg. LSCS 
withST Prev. LSCS in labor Nil
Ni





F Primi Emg. LSCS Failed Induction Nil
Ni
l Nil Nil Nil Nil Nil
98 Rajalakshmi
804
4 24F Primi Emg. LSCS faliure to progress Nil
Ni
l Nil Nil Nil Nil Nil
99 Sulthana
804
2 23F Primi Emg. LSCS CPD Nil
Ni




3 24F Primi Emg. LSCS FD Nil
Ni




0 21F Primi Emg. LSCS FD Nil
Ni




5 24F G2 P1 L0 Emg. LSCS Prev. LSCS  BOH Nil
Ni




9 24F Primi Emg. LSCS FD Nil
Ni




9 20F Primi Emg. LSCS PIH Nil
Ni




2 17F G3 P2 L2 Emg. LSCS CPD / FD Nil
Ni




3 19F Primi Emg.LSCS FD with Oligo Nil
Ni




9 22F Primi Emg.LSCS PP Nil
Ni




0 24F Primi Emg. LSCS Oligo Nil
Ni





G3 P1 L1 
A1 Emg. LSCS Failed ind PIH Rh(-ve) Nil
Ni




2 18F G2 P1 L1 EmgRpt LSCS
prev. LSCS long pd of 
infertility Nil
Ni




0 18F G3 P2 L1 Elect. RPT LSCS Prev. LSCS CPD Nil
Ni




1 19F Primi Emg. LSCS PIH/Breech / Post dated Nil
Ni




3 21F G3 P2 L1 Emg. LSCS  ST Prev LSCS in labour Nil
Ni






6 22F G2 P1 L1
Emg Rpt LSCS 
ST Prev. LSCS in labor Nil
Ni




0 19F G2 P1 L1
Emg. Rpt LSCS 
ST Prev LSCS in labor Nil
Ni





8 18F Primi Emg. LSCS Oilgohydramnios Nil
Ni




4 20F Primi Emg LSCS Sev. Oligo/ Nil
Ni




2 17F G2 P1 L1
Emg Rpt LSCS 
ST Prev. LSCS/ CPD in labor Nil
Ni




1 19F Primi Emg. LSCS CPD Nil
Ni




0 24F Primi Emerg. LSCS PIH / MSAF/ FD Nil
Ni




1 29F Primi Elect LSCS 
Ovarian cyst comp. 
pregCPD Nil
Ni




3 27F Primi Emg LSCS Failed induction Nil
Ni




2 25F G2 A1 Emg. LSCS CPD in Labor Nil
Ni




3 22F Primi Emg. LSCS PIH / imminent symptoms Nil
Ni




0 19F G3 P2 L2
Emg. Rpt. LSCS 
ST Prev. 2 LSCS in labour Nil
Ni











G3 P1 L1 
A1 
Emg Rpt. LSCS 
ST Pre. LSCS / CPD in labour Nil
Ni




4 20F G2 P1 L1
Emg. Rpt LSCS 
ST Prev. LSCS in labour Nil
Ni




3 21F G2 P1 L1
Emg. Rpt LSCS 
ST Prev. LSCS CPD in labor Nil
Ni




5 26F Primi Emg. LSCS FD failed induction Nil
Ni




0 19F Primi Emg. LSCS FD Nil
Ni




1 21F G2 P1 L1
Emg Rpt LSCS 
ST
Prev. LSCS UE Head in 
labor Nil
Ni




9 20F Primi Emg LSCS FD Nil
Ni




1 18F G2 P1 L1
Emg Rpt LSCS 
ST Prev LSCS UEHead Nil
Ni




8 21F G2 P1 L1
Emg Rpt LSCS 
ST Prev LSCS UE Head Nil
Ni




8 21F G2 P1 L1
Emg Rpt LSCS 
ST Prev. LSCS CPD Nil
Ni




7 23F G2 P1 L1 Elect Rpt LSCS Prev. LSCS UE Head Nil
Ni




7 25F G2 P1 L1 Elect Rpt LSCS Prev LSCS Mobile head Nil
Ni




6 20F Primi Emg LSCS CPD Nil
Ni





G3 P1 L1 
A1 Emg. LSCS Prev. LSCS Rh (-ve) CPD Nil
Ni




6 19F Primi Emg. LSCS Severe Oligo Nil
Ni




5 24F Primi Emg. LSCS FD Nil
Ni




4 17F G2 P1 L1 Emg. LSCS FD Nil
Ni




9 25F Primi Emg. LSCS Failed induction Nil
Ni




9 24F Primi Emg. LSCS CPD Nil
Ni





9 20F Primi Elect LSCS CPD Nil
Ni




0 39F Primi Emg. LSCS CPD / PIH in labor Nil
Ni




6 20F Primi Emg. LSCS MSAF Nil
Ni




8 22F G2 P1 L1 Emg. LSCS Prev LSCS  Breech Nil
Ni




7 21F G2 P1 L1
Emg Rpt LSCS 
ST Prev. LSCS +
Ni








2 20F Primi Emg  LSCS CPD with FD Nil
Ni




8 18F G2 P1 L1
Elect Rpt LSCS 








1 22F G2 P1 L1 Elect. Rpt LSCS Prev LSCS CPD Nil
Ni




8 19F G2 P1 L1
Elect Rpt. LSCS 
ST Prev. LSCS with UE Head Nil
Ni





G3 P1 L1 
A1
Elect Rpt. LSCS 
ST Prev. LSCS CPD Nil
Ni




3 20F Primi Emg LSCS
PIH / Fetal dist / Severe 
Oligo Nil
Ni




6 23F Primi Emg. LSCS FD Nil
Ni




8 18F Primi Emg. LSCS FD Nil
Ni




7 24F Primi Emg. LSCS
Short Primi with CPD in 
labour Nil
Ni




3 22F Primi Emg. LSCS FD MSAF Nil
Ni




0 26F G2 P1 L1 Emg Rpt LSCS Prev LSCS CPD Nil
Ni




0 20F Primi Emg.  LSCS MSAF / FD Nil
Ni




4 18F G2 P1 L1
Emg. Rpt. LSCS 
ST Prev LSCS / CPD Nil
Ni




9 19F Primi Emg. LSCS FD Nil
Ni






5 29F G2 P1 L1
Elect Rpt LSCS 
ST Prev. LSCS CPD. Nil
Ni










2 20F Primi Emg LSCS Failed  Induction Nil
Ni





G3 P1 L1 
A1 Emg LSCS Breech in labour Nil
Ni




7 16F G2 P1 L1
Emg Rpt LSCS 
ST Prev. LSCS / Breech Nil
Ni




6 22F Primi Emg. LSCS CPD Nil
Ni




2 26F Primi Emg. LSCS PIH / CPD Nil
Ni




5 22F Primi Emg. LSCS Breech /  PIH Nil
Ni




4 19F Primi Emg. LSCS Fetal alarm signs Nil
Ni




7 20F Primi Emg. LSCS FD Nil
Ni




3 18F Primi Emg. LSCS Severe PIH Nil
Ni






G4 P1 L1 
A2 Emg. Rpt LSCS Prev. LSCS / Sev PIH Nil
Ni










1 20F Primi Emg. LSCS FI +
Ni








2 22F G2 P1 L1 Emg. Rpt LSCS
Prev. LSCS in labour / 
CPD Nil
Ni




8 19F G2 P1 L1 Elect Rpt LSCS Prev. LSCS CPD Nil
Ni




9 20F Primi Emg  LSCS CPD / FD Nil
Ni




3 19F G2 P1 L1
Emg LSCS with 
ST Prev. LSCS CPD Nil
Ni




1 26F Primi Emg LSCS FD Nil
Ni




2 21F Primi Emg LSCS Short Primi / CPD Nil
Ni




6 23F Primi Emg LSCS Oligo Nil
Ni




7 24F G2 P1 L1
Emg LSCS with 
ST Prev. LSCS CPD Nil
Ni




2 20F Primi Emg. LSCS FD with thick MSAF +
Ni






7 25F Primi Emg. LSCS FI Nil
Ni




0 24F Primi Emg. LSCS Thick MSAF FD Nil
Ni






8 19F G2 A1 Emg. LSCS FI Nil
Ni




8 25F Primi Emg. LSCS IUGR / Oligo Nil
Ni




2 23F G2 P1 L1 
Eng Rpt LSCS 
ST Prev LSCS CPD in labor Nil
Ni




3 21F G2 P1 L1
Emg. Rpt LSCS 
ST Hydramnios CPD in labor Nil
Ni






7 22F G2 A1 Emg. LSCS Failure to progress Nil
Ni




6 18F Primi Emg. LSCS Breech  footling Nil
Ni




8 17F Primi Emg. LSCS Long Pd of inf / MSAF/FD Nil
Ni




4 20F G2 P1 L1 Emg. LSCS CPD Nil
Ni




9 19F Primi Emg. LSCS MSAFFetal alarm signs Nil
Ni




0 18F Primi Emg. LSCS FI Nil
Ni




2 22F Primi Emg. LSCS OligoHydramnios Nil
Ni




8 18F G2 P1 L1
Emg LSCS with 
ST Prev LSCS in labor Nil
Ni




9 24F Primi Emg LSCS CPD/Fetal distress Nil
Ni




2 22F G2 P1 L1 Emg LSCS Prev. LSCS post datism Nil
Ni




1 16F G2 P1 L1 Emg LSCS Prev. LSCS CPD in labor Nil
Ni




6 19F Primi Emg LSCS Oligo with FD Nil
Ni





3 18F G2 P1 L1
Emg. LSCS with 
ST Prev LscsUE Head Nil
Ni




7 21F Primi Emg LSCS Oligo Nil
Ni




8 19F G3 P2 L2
Emg. Rpt LSCS 
ST Prev. LSCS UE Head Nil
Ni










4 20F Primi Emg.  LSCS FD Nil
Ni





G2 P1 L1 Emg. Rpt LSCS 
ST Prev. LSCS FD Nil
Ni





G2 P1 L1 Emg. Rpt LSCS 
ST Prev. LSCs with UEHead Nil
Ni





G2 P1 L1 Emg. Rpt LSCS 
ST Prev LSCS with CPD Nil
Ni





G2 P1 L1 Emg. Rpt LSCS 
ST Prev. LSCS Nil
Ni





G2 P1 L1 Emg. Rpt LSCS 
ST
Prev. LSCS / CPD in 
labour Nil
Ni




1 22F G2 A1 Emg. LSCS
Residual Polio CPD in 
Labor Nil
Ni




1 20F G2 P1 L1 Emg Rpt LSCS Prev LSCS with CPD Nil
Ni




4 22F Primi Emg. LSCS Short Primi with CPD Nil
Ni




0 22F Primi Emg. LSCS Short Primi with CPD Nil
Ni




3 22F Primi Emg. LSCS Oligo with FD Nil
Ni




7 19F G2 P1 L1
Emg.Rpt LSCS 
ST Prev. LSCS in labor Nil
Ni




4 26F Primi Emg. LSCS Oligohydramnios Nil
Ni




3 25F G2 P1 L1 Emg LSCS Prev. LSCS / CPD Nil
Ni




8 22F G2 P1 L1 Emg Rpt LSCS Prev LSCS / CPD in labor Nil
Ni




8 21F G2 P1 L1 ElectRpt LSCS ST Prev. LSCS Nil
Ni




5 23F G2 P1 L1 Emg LSCS Type III PP / Bleeding PV Nil
Ni




2 28F G2 P1 L1 Elect Rpt. LSCS Prev. LSCS / Oligo Nil
Ni




7 22F G2 P1 L1
Elect Rpt LSCS 
ST Prev. LSCS/CPD in labour Nil
Ni




5 24F G2 P1 L1 Emg Rpt LSCS Prev. LSCS / CPD in labor Nil
Ni







Emg Rpt LSCS 
ST Prev LSCS in labor Nil
Ni




8 22F Primi Emg LSCS Failure to Progress Nil
Ni




2 24F Primi Emg LSCS MSAF with      FD Nil
Ni




6 20F G2 P1 L0 Emg LSCS BOH with Oblique lie Nil
Ni




7 20F Primi Emg LSCS CPD in labour Nil
Ni




7 26F G2 P1 L1
Emg. LSCS with 
ST Prev LSCS/ CPD in Labor Nil
Ni





6 19F Primi Emg LSCS Failure to Progress Nil
Ni




1 19F G2 P1 L1 Emgrpt LSCS  ST Prev LSCS UE head Nil
Ni




7 26F Primi Emg LSCS B/L residnal Polio / CPD Nil
Ni




2 19F G3 P2 L1
Emg. Rpt. LSCS 
ST Prev. 2 LSCS Nil
Ni




4 18F Primi Emg. LSCS CPD / PIH Nil
Ni




6 17F G2 P1 L1
Emg. LSCS with 
ST Breech Nil
Ni




6 19F G2 P1 L0 Emg. LSCS Prev. LSCS/ CPD Nil
Ni




8 17F G3 P2 L2
Emg. LSCS with 
ST Prev LSCS Nil
Ni




4 19F Primi Emg. LSCS Breech Nil
Ni




0 16F G5 P4 L2
Emg Rpt LSCS 
ST PIH / Prev LSCS in labour +
Ni








2 23F Primi Emg LSCS MSAF / FD Nil
Ni










7 22F G2 P1 L1
Emg Rpt LSCS 
ST Prev. LSCS/ CPD in labour Nil
Ni




6 28F G2 P1 L1
Emg Rpt LSCS 
ST Prev LSCS / CPD Nil
Ni




0 18F Primi Emg LSCS CPD Nil
Ni




1 19F G2 P1 L1 Em. Rpt  LSCS Prev. LSCS Nil
Ni




0 18F G2 A1 Em. LSCS CPD Nil
Ni




8 23F Primi Emer. LSCS Breech Nil
Ni




6 25F G2 P1 L1 Elect  Rpt LSCS Prev. LSCS Nil
Ni







G5 P2 L1 
A2 Elec LSCS BOH,   GDM Nil
Ni






L1A1 Elec.  LSCS ST Prev.    LSCS Nil
Ni




4 18 G2 P1 L1 Emer. LSCS ST Prev.    LSCS Nil
Ni




7 21F G2 P1 L1 Emer. LSCS Prev.    LSCS Nil
Ni




8 18F Primi Emer. LSCS CPD Nil
Ni




0 25F Primi Emer. LSCS Long pd infertility Nil
Ni




6 26F Primi Emer. LSCS Post dated PIH Nil
Ni




6 26F Primi Emer. LSCS Oliogohydramnios Nil
Ni




9 29F G2 P1 L1 Emer Rpt LSCS Prev. LSCS Nil
Ni




9 23F Primi Emer LSCS Short  Stature Nil
Ni




4 31F G3 P2 L2 Emer LSCS ST Prev.    LSCS Nil
Ni







6 28F Primi Emer LSCS Fetal  Distress oligo Nil
Ni




1 22F G2 P1 L1 Emer  LSCS Severe Oligo Nil
Ni




5 29F Primi Emer. LSCS Breech Nil
Ni




6 27F G2 P1 L1 Emer. Rpt LSCS PrevLscs Nil
Ni




5 19F Primi Emer. LSCS Failed induction Nil
Ni




4 21F Primi Emer  LSCS CPD Nil
Ni




3 21F Primi Emer LSCS PIH / CPD Nil
Ni





G2 P1 L1 Emer Rpt LSCS 
ST Prev. LSCS Nil
Ni





G2 P1 L1 Emer Rpt LSCS 
ST Prev. LSCS +
Ni
















Emeg. Rpt LSCS Prev. LSCS Nil
Ni






Emeg. LSCS Obstructed labour Nil
Ni




3 28F Primi Emer  LSCS Fail to progress Nil
Ni




3 21F G2 A1 Emer LSCS Oligo hydram Nil
Ni




6 22F G2 P1 L1
Emer Rpt LSCS 
ST Prev. LSCS Nil
Ni




6 21F Primi Emer. LSCS Tranverse  Lie Nil
Ni




0 21F Primi Emer  LSCS PIH / Twins Nil
Ni




7 26F G2 P1 L1 Emer. LSCS. Prev.  LSCS Nil
Ni




2 23F Primi Eme. LSCS Fetal distress Nil
Ni




3 22F Primi Emer LSCS Fetal distress Nil
Ni






7 25F G4 P3 L2 Emer LSCS Tr. Lie Nil
Ni




4 20F Primi Emer. LSCS MSAF Nil
Ni




0 21F G2 P1 L1 Em.   LSCS Prev. LSCS Nil
Ni






4 21F Primi Emer LSCS MSAF / FD Nil
Ni




5 28F G3 P2 L2
Emer RPT LSCS 
ST Prev. LSCS Nil
Ni




4 22F Primi Emer LSCS FD Nil
Ni




0 29F G2 P1 L1 EmerRpt. LSCS Prev.    LSCS Nil
Ni




2 27F G3 P2 L1
EmerRpt. LSCS 
ST Prev.    LSCS Nil
Ni




4 24F G2 P1 L1
Emer Rpt. LSCS 
ST Prev.    LSCS Nil
Ni





G3 P1 L1 
A1 Emer. LSCS Prev.    LSCS Nil
Ni





0 21F Primi Emer. LSCS PIH /      Oligo Nil
Ni






Emer. LSCS Prev.     LSCS Nil
Ni






Emer. LSCS ST Prev.    LSCS Nil
Ni






Emer. LSCS ST Prev.    LSCS Nil
Ni






Emer. LSCS Prev.    LSCS Nil
Ni





G4 P2 L1 
A1 Emer. LSCS  ST Prev.    LSCS Nil
Ni




8 19F G3 P2 L2 Emer. LSCS ST Prev.    LSCS Nil
Ni




2 19F Primi Emer. LSCS Fetal Distress Nil
Ni




4 18F Primi Emer. LSCS Fetal Distress Nil
Ni





G3 P1 L1 
A1 Emer. LSCS ST Prev.    LSCS Nil
Ni






4 18F Primi Emer. LSCS Oigohy. dramnios Nil
Ni




8 18F Primi Emer. LSCS FD Nil
Ni




9 19F Primi Emer LSCS Failed Induction Nil
Ni




1 22F Primi Emer. LSCS Failed induction Nil
Ni




9 20F Primi Emer. LSCS FD Nil
Ni




2 25F Primi Emer. LSCS Primi / Twin /FD Nil
Ni




0 24F G2 P1 L1 Emer Rpt. LSCS Prev.     LSCS Nil
Ni




9 21F Primi Emer. LSCS PIH / Gr II Abruptio Nil
Ni




7 18F G2 A1 Emer. LSCS BOH, IUGR Oligo Nil
Ni





G4 P2 L0 
A1 Emer. LSCS BOH, POstdated Nil
Ni




2 22F Primi Emer. LSCS failed Induction Nil
Ni




5 23F Primi Emer. LSCS FD Nil
Ni




8 21F Primi Emer. LSCS FD Nil
Ni




2 20F Primi Emer.LSCS FD Nil
Ni




6 21F Primi Emer.LSCS CPD Nil
Ni




4 21F G2 P1 L1 Emer. Rpt  LSCS Prev. LSCS Nil
Ni





G5 P1 L1 
A3
Emer.  Rpt LSCS 
ST Prev. LSCS Nil
Ni




2 21F Primi Emer. LSCS  FD Nil
Ni




1 23F Primi Emer. LSCS Breech Nil
Ni




4 23F G3 P2 L2 Emer. LSCS ST Foetal  Distress Nil
Ni





1 19F G2 P1 L1 Emer. LSCS ST Prev.  LSCS Nil
Ni




7 25F Primi Emer. LSCS PIH / Failed induction Nil
Ni




3 23F Primi Emer.  LSCS MSAF Nil
Ni




2 26F Primi Emer. LSCS FD Nil
Ni






Emer. LSCS Oliog Hydra Nil
Ni






Emer.  LSCS Prev. LSCS Nil
Ni





G2 P1 L1 Elec RPT LSCS 
ST Prev. LSCS Nil
Ni




0 18F G2 P1 L1 
Elec RPT LSCS 
ST Prev. LSCS Nil
Ni




8 21F G2 P1 L1 Elec RPT LSCS Prev. LSCS Nil
Ni




5 25F Primi Elective LSCS Long PD OFInfertity Nil
Ni




8 23F Primi Elec. LSCS Primi Oligo Nil
Ni






Emer. LSCS Oligo with  CPD +
Ni










Emer. LSCS PIH failed induction Nil
Ni




4 21F Primi Emer. LSCS FD Nil
Ni




6 20F G3 A2 Emer. LSCS BOH Nil
Ni




6 25F G2 P1 L1 Emer.Rpt LSCS Prev. LSCS Nil
Ni




6 19F Primi Emer. LSCS Failed induction Nil
Ni




2 22F Primi Emer. LSCS PIH/CPD / Oligo Nil
Ni




1 20F Primi Emer. LSCS PIH/CPD / FD Nil
Ni




7 18F G2 P1 L1 Emer.Rpt  LSCS Prev. LSCS Nil
Ni




0 23F Primi Emer. LSCS Failed Induction Nil
Ni




8 20F Primi Emer. LSCS FD Nil
Ni






Emer Rpt LSCS Pre Lscs Nil
Ni






Emer. LSCS Occ. Post / FD Nil
Ni






Emer. Rpt  LSCS Prev. LSCS Nil
Ni




8 22F Primi Emer. LSCS Failed induction. Nil
Ni






6 22F G2 P1 L1 Emer. Rpt  LSCS Prev. LSCS Nil
Ni




2 23F Primi Emer.  LSCS FD Nil
Ni




0 19F G2 P1 L1 Emer. LSCS Failed  induction Nil
Ni






8 26F Primi Emer.  LSCS FD Nil
Ni





4 19F Primi Emer. LSCS Breech Nil
Ni




5 21F Primi Emer. LSCS PROM / CPD Nil
Ni




8 21F Primi Emer.  LSCS Breech / FD Nil
Ni






L1A2 Emer. LSCS ST Prev.     LSCS Nil
Ni






3 19F Primi Emer. LSCS CPD Nil
Ni




3 24F G3 P2 L2 Emer. LSCS FD/Obstru. Labor Nil
Ni




5 25F G2 P1 L1 Emer.  LSCS FD Nil
Ni




0 19F Primi Emer.  LSCS CPD IInd Nil
Ni






Emer. LSCS Prev. LSCS / Oligo Nil
Ni








Emer.  LSCS Prev. LSCS Nil
Ni





G3 P1 L1 
A1 Emer. LSCS ST Prev.  LSCS Nil
Ni




3 20F G2 P1 L1 Emer. LSCS Failed induction Nil
Ni




3 16F Primi Emer. LSCS PIH / Primi / CPD Nil
Ni




3 23F G2 P1 L1 Emer. LSCS Prev. LSCS / FD Nil
Ni






L1 Emer. LSCS Prev. LSCS CPD Nil
Ni







G3 P1 L1 
A1 Emer. LSCS ST Prev. LSCS Nil
Ni




1 21F G2 P1 L1 Emer. LSCS Prev. LSCS Nil
Ni




8 21F Primi Emer. LSCS Oliogohydramnios Nil
Ni




6 21F Primi Emer. LSCS CPD Nil
Ni




3 19F G3 P2 L1 Emer. LSCS Fetal DISTRESS Nil
Ni





G3 P1 L0 
A1 Emer. LSCS BOH with PIH Nil
Ni




1 21F G2 P1 L1 Emer. LSCS MSAF Nil
Ni




8 21F Primi Emer. LSCS MSAF Nil
Ni




5 22F G3 P2 L2 Emer. LSCS Breech Nil
Ni




7 21F G3 P2 L2 Emer. LSCS FD Nil
Ni




9 23F G2 P1 L0 Emer. LSCS BOH/  Polio Nil
Ni







G3  P2 
L2 Emer. LSCS ST Prev.  LSCS Nil
Ni




2 19F Primi Emer. LSCS Brow. Nil
Ni




4 24F G2 P1 L1
Elective   LSCS 
ST Prev. LSCS Nil
Ni






2 18F G4 P3 L2 Emer. LSCS Prev. LSCS Nil
Ni





0 23F Primi Emer. LSCS Breech Nil
Ni




3 19F G2 A1 Emer.LSCS PIH /CPD Nil
Ni




1 20F Primi Emer. LSCS CPD Nil
Ni




8 25F Primi Emer. LSCS PIH with CPD Nil
Ni






Emer. LSCS Prev. LSCS Nil
Ni






Emer. LSCS ST Prev. LSCS Nil
Ni










6 20F G2 P1 L1 Emer. LSCS Failed induction Nil
Ni





G3 P1 L0 
A1 Emer. LSCS BOH with PIH  cpd Nil
Ni




3 18F G2 P1 L1
Emer Rpt LSCS 
ST Prev. LSCS Nil
Ni






4 19F G2 P1 L1 Emer Rpt  LSCS Prev. LSCS Nil
Ni




2 22F Primi Emer. LSCS CPD Nil
Ni




5 21F Primi Emer. LSCS CPD Nil
Ni




0 21F G2 P1 L1
Elective Rpt Lscs 
st Prev. LSCS Nil
Ni




2 19F G2 P1 L1 EM Rpt LSCS ST Prev. LSCS Nil
Ni




7 27F Primi Emer. LSCS Breech Nil
Ni




9 19F G2 A1 Emer. LSCS Breech Nil
Ni




8 23F Primi Emer. LSCS Foetal distress Nil
Ni





G3 P1 L1 
A1 Emer. LSCS Type II Posterior PP Nil
Ni






4 21F Primi Emer. LSCS Failure to Progress Nil
Ni






2 29F Primi Emer. LSCS CPD Nil
Ni




3 25F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni




4 23F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni




5 24F Primi Emer. LSCS Long Pd of Infertility Nil
Ni




2 21F G2 A1 Emer. LSCS CPD Nil
Ni




3 21F Primi Emer. LSCS MSAF with FD Nil
Ni





G4 P3 L1 
A0 Emer. LSCS BOH with Trans lie Nil
Ni




1 20F Primi Emer. LSCS Failed induction With FD Nil
Ni




6 21F Primi Emer. LSCS Failed induction Nil
Ni





G4 P1 L1 
A2 Emer. LSCS PIH / FD Nil
Ni





5 21 Primi Emer. LSCS Breech Nil
Ni




8 19F Primi Emer. LSCS FailureTo Progress Nil
Ni




8 18F G3 P2 L2 Emer. LSCS ST CPD Nil
Ni




0 28F G2 P1 L0 Emer. LSCS PHI/failed induction Nil
Ni




6 18F G2 P1 L1 Emer. LSCS ST PHI/failed induction Nil
Ni




8 35F Primi Elective LSCS Twin Nil
Ni






8 25F G2 P1 L1
ElectiveRpt 
LSCS Prev. LSCS Nil
Ni




9 23F Primi Emer. LSCS FD Nil
Ni




4 22F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni




1 21F Primi Emer. LSCS CPD/ Rh – ve Nil
Ni




7 19F Primi Emer. LSCS FD Nil
Ni




8 26F Primi Emer. LSCS FD Nil
Ni





G2 P1 L1 Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni






Emer. LSCS FD Nil
Ni




9 18F G2 A1 Emer. LSCS CPD Nil
Ni




7 21F G2 A1 Emer. LSCS PIH Nil
Ni




9 21F Primi Emer. LSCS CPD Nil
Ni





G2 P1 L1 Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni





G2 P1 L1 Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni





G3 P1 L1 
A1 
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni






Emer. LSCS  Oligohydramnios Nil
Ni






Emer. LSCS Breech Nil
Ni




3 20F G3 P2 L1
Elective Rpt LSCS 
ST Prev. 2 LSCS Nil
Ni




4 20F G2 P1 L1
Elective Rpt LSCS 
ST Prev. LSCS Nil
Ni




5 18F G2 P1 L1
Elective Rpt LSCS 
ST Prev. LSCS Nil
Ni





G2 P1 L1 Elective Rpt LSCS 
ST Prev. LSCS Breech Nil
Ni






Elective Rpt LSCS Prev. LSCS Nil
Ni




9 22F Primi Emer LSCS CPD /  MSAF Nil
Ni




5 19F Primi Emer. LSCS AP ecclampria Nil
Ni




6 19F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni





8 21F Primi Emer. LSCS MSAF with FD Nil
Ni




5 25F Primi Emer. LSCS Foetal distress. Nil
Ni




1 18F Primi Emer. LSCS Sort Primi CPD Nil
Ni




7 21F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni






3 18F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni




4 21F Primi Emer. LSCS PIH / CPD Nil
Ni




9 18F Primi Emer. LSCS PHI / FD Nil
Ni




6 21F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni




6 19F G2 P1 L1 Emer Rpt. LSCS Prev. LSCS Nil
Ni




4 20F Primi Emer. LSCS Fetal distress Nil
Ni




9 21F Primi Emer. LSCS Breech Nil
Ni




7 22F Primi Emer. LSCS FD Nil
Ni




4 23F G2 A1 Emer. LSCS Foetal alarm Sign Nil
Ni




5 21F G2 P1 L1
Emer Rpt. LSCS 
ST Prev.   LSCS Nil
Ni




9 20F Primi Emer. LSCS Breech Nil
Ni




9 20F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni






6 20F Primi Emer. LSCS FD Nil
Ni





G3 P1 L1 
A1 
EmerRpt. LSCS 
ST Prev. LSCS Nil
Ni






8 32F G2 A1 Emer. LSCS PIH / CPD Nil
Ni






6 24F Primi Emer. LSCS CPD Nil
Ni




3 32F G2 P1 L1
EmerRpt. LSCS 
ST Prev. LSCS Nil
Ni




5 19F Primi Emer. LSCS Failure to prog. Nil
Ni






5 23F G2 P1 L1 Emer. LSCS ST Prev. LSCS, Breech Nil
Ni




6 22F Primi Emer. LSCS Breech Nil
Ni




1 21F Primi Emer. LSCS PIH / Failed induction Nil
Ni




0 23F Primi Emer. LSCS Failure to progress Nil
Ni




3 20F Primi Emer. LSCS Failed induction Nil
Ni




5 24F G2 P1 L1 Emer. LSCS Breech/ Footling Nil
Ni




5 23F G2 P1 L1 Emer. LSCS FD Nil
Ni




2 26F G2 P1 L1
Emer Rpt. LSCS 
st Prev. LSCS Nil
Ni





3 24F Primi Emer. LSCS Severe Oligo Nil
Ni




2 20F Primi Emer. LSCS Failed Induction Nil
Ni




2 19F Primi Emer. LSCS Fetal Distress Nil
Ni




6 22F G2 P2 L1
Emer.Rpt 
LSCSST Prev.   LSCS Nil
Ni




7 20F G2 P1 L1
Emer.Rpt 
LSCSST Prev.   LSCS Nil
Ni





G3 P1 L1 
A1 Emer. LSCSST Prev.   LSCS Nil
Ni




0 21F G2 P1 L0 Elective LSCS BOH/ PIH Nil
Ni




6 21F Primi Emer. LSCS Failure to progress Nil
Ni






6 19F Primi Emer. LSCS PIH / Fail Induc. Nil
Ni




9 18F G2 P1 L1 Emer. LSCS ST Cicatrised Cx Nil
Ni




2 23F Primi Emer. LSCS Breech / Oligo Nil
Ni




3 22F G3 P2 L1 Emer. LSCS Prev. LSCS / Oligo Nil
Ni




4 24F Primi Emer. LSCS Severe    PIH Nil
Ni




1 22F G2 P1 L1
Emer Rpt. LSCS 
ST Prev.    LSCS Nil
Ni




2 24F G2 P1 L1
Emer Rpt. LSCS 
ST Prev. LSCS Nil
Ni
l Nil Nil Nil Nil Nil
79








Surgery Indication Wound UTI Fever Adverse Abnormal Organisms Other
N






0 19F G2 P1 L1
Em Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil
3 Selvi
1895
1 27F G3 P2 L2
Em. Rpt LSCS 




l Nil Nil Nil Nil
4 Vijaya
1893




l Nil Nil Nil Nil




l Nil Nil Nil Nil
6 Nadhiya 13 28F Primi EM LSCS Failure to Progress Nil + + Nil Nil E.coli
Nor 
floxacin
7 Kannammmal 30 24F G2 P1 L1
Emerg Rpt 








G2 P1 L1 Em Rpt LSCS 




l Nil Nil Nil Nil
9 Saritha 47 17F
G2 P1 L1 Em. Rpt LSCS 













l Nil Nil Nil Nil
11 Prema
1894




l Nil Nil Nil Nil




l Nil Nil Nil Nil
13 Kala 44 19F Primi Em. LSCS Failed induction +
Ni











l Nil Nil Nil Nil
15 Kamatchi 10 30F
G4 P1 L1 
A2
El. Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
18 Gayathri 50 23F G2 P1 L1 EM.RPT LSCS Prev LSCS + + + Nil Nil E.coli
Norfloxaci
n




l Nil Nil Nil Nil
20 Prema 79 21F G2 P1 L1
Em. Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil
22 Devi 76 19F Primi Em. LSCS





l Nil Nil Nil Nil
23 Vijaya
1894




l Nil Nil Nil Nil
80




l Nil Nil Nil Nil




l Nil Nil Nil Nil
26 Umamaheswari
1895






l Nil Nil Nil Nil
27 Vani
1767
2 21F G2 P1 L1 Em. LSCS Prev LSCS Breech +
Ni









l Nil Nil Nil Nil
29 Sahana Banu 65 21F
G3 P1 L1 




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
33 Vijayalakshmi 93 21F Primi Em. LSCS PIH CPD Nil +
Ni
l Nil Nil E.coli
Nor 
floxacin




l Nil Nil Nil Nil
35 Vimala
1871
9 20F G3 P2 L2
EL. Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
43 Grace Arul Mari 129 22F Primi Em. LSCS Oligo Hydramnios Nil
Ni
l + Nil Nil Nil
Chloroqui
ne 
44 Mariammal 140 16F G2 P1 L1
Em. Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil









47 Lalithadevi 163 23F
Prev 




l Nil Nil Nil Nil
48 Jayanthi 165 24F G2 P1 L1
Em. PRT LSCS 




l Nil Nil Nil Nil
49 Pappa 166 22F G2 P1 L1
Em. Rpt LSCS 




l Nil Nil Nil Nil
50 Senthoorkani
1885




l Nil Nil Nil Nil
51 Radhika
1877











l Nil Nil Nil Nil
81




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
56 Dhanalakshmi 133 18F G2 P1 L1 Em. LSCS  ST Failed ind. Nil
Ni
l + Nil Nil Nil
Chloroqui
ne 
57 Aubarasi 195 24F G2 P1 L1
Em. Rpt LSCS 




l Nil Nil Nil Nil
58 Bommi
1843




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil








l Nil Nil Nil Nil
62 Hemavathy 211 19F G2 P1 L1
Emer Rpt. 




l Nil Nil Nil Nil
63 Devi 218 20F Primi Emerg LSCS FD Nil +
Ni
l Nil Nil E.coli
Nor 
floxacin
64 Ramani 154 21F Primi Emerg LSCS FD Nil
Ni





3 22F G2 P1 L1
Elect. Rpt LSCS 




l Nil Nil Nil Nil
66 Sheynbanu 171 22F Primi Eme. LSCS





l Nil Nil Nil Nil
67 Amudha 2013 27F
G4 P1 L1 
A2 Emerg. LSCS
PIH with BOH with 
CPD Nil +
Ni
l Nil Nil Klebsiella
Ciprofloxa
cin








l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
71 Selvalakshmi 267 19F
G4 P1 L1 
A2
Emerg Rpt Lscs 




l Nil Nil Nil Nil




l Nil Nil Nil Nil
73 Vasanthi 191 17F
G3 P1 L1 




l Nil Nil Nil Nil
74 Deepa 243 21F Primi Emeg LSCS Fetal alarm Sign Nil
Ni
l + Nil Nil Proteus 
Ciprofloxa
cin




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
81 Hemavathy 98 24F
G3 P1 L1 
A1
Emeg Rpt LSCS 




l Nil Nil Nil Nil
82




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
86 Selvamary 215 23F Primi Emeg LSCS MSAF with FD Nil
Ni
l + Nil Nil Nil
Chloroqui
ne 
87 Sadarimmal 299 18F G3 P2 L2 
Emeg Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
90 Saroja 336 20F G6  A5 Emeg LSCS BOH with CPD Nil +
Ni
l Nil Nil E.coli
Nor 
floxacin
91 Parveen banu 38 26F
G3 P1 L1 
A1
Emeg Rpt LSCS 




l Nil Nil Nil Nil




l Nil Nil Nil Nil
93 Suguna 247 24F
G4 P1 L1 




l Nil Nil Nil Nil




l Nil Nil Nil Nil




l Nil Nil Nil Nil
96 Kavitha 180 21F Primi Emeg. LSCS





l Nil Nil Nil Nil




l Nil Nil Nil Nil
98 Indra 245 19F G2 P1 L1 
Emer. Rpt 
LSCS BOH with Prev LSCS Nil
Ni
l + Nil Nil Nil
Chloroqui
ne 
99 Selvi 366 25F G2 P1 L1 
Emeg. Rpt 
LSCS Prev. LSCS Nil
Ni
l + Nil Nil Nil Nil
10
0 Vinodhini 346 25F G2 P1 L1 
Emeg Rpt LSCS 




l Nil Nil Nil Nil
10




l Nil Nil Nil Nil
10




l Nil Nil Nil Nil
10
3 Sugnaya 382 17F
G4 P1 L1 




l Nil Nil Nil Nil
10




l Nil Nil Nil Nil
10
5 Sangeetha 66 23F G2 P1 L1 
Emeg Rpt LSCS 
ST Prev. LSCS Nil +
Ni










l Nil Nil Nil Nil
10
7 Meenaktchi 301 27F G2 P1 L1 
Electr Rpt LSCS 
ST Prev. LSCS Nil
Ni
l + Nil Nil Nil Nil
10
8 Devi 388 17F G2 P1 L1 
Emeg. Rpt 








9 Vijaya 208 28F G2 P1 L1 
Emeg. Rpt 




l Nil Nil Nil Nil
11
0 Lilly 104 32F
G3 P1 L1 
A1
Emeg. Rpt 




l Nil Nil Nil Nil
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11
1 Kalaiselvi 377 24F
G3 P1 L1 
A1
Emeg. Rpt 




l Nil Nil Nil Nil
11
2 Renuka 398 27F G5  A4 Emeg LSCS





l Nil Nil Nil Nil
11




l Nil Nil Nil Nil
11








i 397 25F G2 P1 L1 Emeg LSCS





l Nil Nil Nil Nil
11




l Nil Nil Nil Nil
11
7 Laureace Mary 433 20F G2 P1 L1 
Emeg Rpt LSCS 








4 23F G2 P1 L1 
Em. LSCS with 




l Nil Nil Nil Nil
11
9 Viji 357 30F
G4 P1 L1 
A2
Elect. Rpt LSCS 




l Nil Nil Nil Nil
12
0 Thilagavathi 319 23F
G4 P2 




l Nil Nil Nil Nil
12
1 Dhanalakshmi 2514 24F
G3 P1 L1 
A1
Elect Rpt LSCS 




l Nil Nil Nil Nil
12
2 Eswari 443 22F G2 P1 L1 
Emeg Rpt LSCS 




l Nil Nil Nil Nil
12
3 Devi 428 24F
G4 P1 L1 
A2
Emeg Rpt LSCS 
ST Breech in labour Nil
Ni








l Nil Nil Nil Nil
12




l Nil Nil Nil Nil
12




l Nil Nil Nil Nil
12




l Nil Nil Nil Nil
12
8 Rani 466 21F G2 P1 L1 
Emeg. Rpt 




l Nil Nil Nil Nil
12
9 Chandra 465 25F G2 P1 L1 
Emeg . Rpt 




l Nil Nil Nil Nil
13
0 Vijitha 485 31F G2 P1 L1 Emeg LSCS MSAF FD Nil
Ni




1 Nagamma 392 28F G2 P1 L1 
Emg RPt LSCS 




l Nil Nil Nil Nil
13
2 Sharmita 128 23F
G4 P1 L1 




l Nil Nil Nil Nil
13




l Nil Nil Nil Nil
13
4 Renuka 426 24F Primi Emeg LSCS Foetal distress Nil +
Ni




5 Bharathi 500 27F G2 P1 L1 
Emeg Rpt. 




l Nil Nil Nil Nil
13
6 Kalpana 510 23F Primi Emeg LSCS





l Nil Nil Nil Nil
13




l Nil Nil Nil Nil
13
8 Mythili 516 19F G2 P1 L1 
Emg Rpt LSCS 




l Nil Nil Nil Nil
13
9 Kanmani 504 21F Primi Emeg LSCS Imm Ecclampsia Nil
Ni









l Nil Nil Nil Nil
14




l Nil Nil Nil Nil
14




l Nil Nil Nil Nil
14
3 Gabeira 178 28F Primi Emeg. LSCS PIH Failed induction Nil +
Ni
l Nil Nil Nil Nil
14




l Nil Nil Nil Nil
14
5 Sujatha 514 20F Primi Emeg LSCS





l Nil Nil Nil Nil
14
6 Jaya 543 25F G2 P1 L1
Emey Rpt LSCS 
ST
Prev LSCS post 
dated Nil +
Ni




7 Rajeswari 545 20F G2 P1 L1
Emgy Rpt. 




l Nil Nil Nil Nil
14




l Nil Nil Nil Nil
14
9 Fathima 547 25F Primi Emeg. LSCS Fetel distress Nil
Ni








l Nil Nil Nil Nil
15




l Nil Nil Nil Nil
15




l Nil Nil Nil Nil
15




l Nil Nil Nil Nil
15




l Nil Nil Nil Nil
15
5 Sanjulatha 566 28F G2 P1 L1 Emeg LSCS





l Nil Nil Nil Nil
15
6 Ajantha 576 24F G2 P1 L1 Emg LSCS





l Nil Nil Nil Nil
15






l Nil Nil Nil Nil
15




l Nil Nil Nil Nil
15
9 Saheena 615 23F G2 P1 L1
Emg. Rpt LSCS 




l Nil Nil Nil Nil
16




l Nil Nil Nil Nil
16
1 Jothy 644 22F G2 P1 L1
Emeg. Rpt 




l Nil Nil Nil Nil
16
2 Usha 654 16F
G4 P1 L1 
A2 
Em Rpt LSCS 




l Nil Nil Nil Nil
16








3 17F G2 P1 L1 Em. Rpt LSCS Prev LSCS CPD Nil
Ni








l Nil Nil Nil Nil
16




l Nil Nil Nil Nil
16




l Nil Nil Nil Nil
16




l Nil Nil Nil Nil
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16




l Nil Nil Nil Nil
17
0 Nagajothi 692 24F
G3 P1 L1 
A1 
Emg Rpt. LSCS 




l Nil Nil Nil Nil
17
1 Budhurninta 687 25F
G3 P1 L1 
A1
Emg LSCS with 




l Nil Nil Nil Nil
17




l Nil Nil Nil Nil
17




l Nil Nil Nil Nil
17
4 Kalaiselvi 660 26F G2 P1 L1 





l Nil Nil Nil Nil
17




l Nil Nil Nil Nil
17
6 Reginamary 716 21F
G3 P1 L1 




l Nil Nil Nil Nil
17










l Nil Nil Nil Nil
17
9 Faritha 733 36F
G3 P1 L1 
A1
Emg. Rpt LSCS 




l Nil Nil Nil Nil
18












l Nil Nil Nil Nil
18




l Nil Nil Nil Nil
18
3 Punitha 734 22F G2 P1 L1 
Emg Rpt LSCS 




l Nil Nil Nil Nil
18
4 Chitra 760 38F G2 P1 L1 Emer LSCS Elder grad / CPD Nil +
Ni






















l Nil Nil Nil Nil
18




l Nil Nil Nil Nil
18




9 Malliya 579 23F G2 P1 L1 El Rpt LsCS  ST





l Nil Nil Nil Nil
19
0 Vijayalaksmi 583 20F G2 P1 L1
Elec Rpt LSCS 




l Nil Nil Nil Nil
19
1 Jeyanathi 694 23F Primi Emeg LSCS PIH with CPD Nil +
Ni
l Nil Nil Nil Nil
19




l Nil Nil Nil Nil
19
3 Kumari 758 32F G5 P4 L1
Emy. Rpt LSCS 




l Nil Nil Nil Nil
19
4 Banu 808 24F G3 P2 L2
Emy Rpt LSCS 




l Nil Nil Nil Nil
19
5 Clara 795 22F G2 P1 L1 
Emy Rpt LSCS 




l Nil Nil Nil Nil
19
6 Divya 807 17F Primi Emy LSCS Oligohydramnios Nil +
Ni















8 Megala 803 20F Primi Emeg. LSCS PIH Breech Nil
Ni








l Nil Nil Nil Nil
20








l Nil Nil Nil Nil
20




l Nil Nil Nil Nil
20




l Nil Nil Nil Nil
20




l Nil Nil Nil Nil
20
5 Sathyakala 840 24F G2 P1 L1
Eny Rpt LSCS 




l Nil Nil Nil Nil
20




l Nil Nil Nil Nil
20




8 Selvi 855 21F G2 P1 L1
Emeg. Rpt 




l Nil Nil Nil Nil
20




l Nil Nil Nil Nil
21




l Nil Nil Nil Nil
21
1 Anandhi 849 18F G3 P2 L2
Em. Rpt. LSCS 




l Nil Nil Nil Nil
21








l Nil Nil Nil Nil
21
4 Geetha 875 22F G2 P1 L1
EM. Rpt LSCS 




l Nil Nil Nil Nil
21
5 Chitra 745 23F G2 P1 L1
EM. Rpt LSCS 




l Nil Nil Nil Nil
21
6 Padmapriya 860 21F G3 P2 L1
Em. Rpt LSCS 




l Nil Nil Nil Nil
21




l Nil Nil Nil Nil
21




l Nil Nil Nil Nil
21
9 Vijaya 859 19F
G4 P1 L1 
A2 
Em. Rpt LSCS 




l Nil Nil Nil Nil
22
0 Nazreen Sultan 937 26F Primi Em. LSCS F.D Nil
Ni




1 Shanthi 874 30F
G3 P1 L1 
A1
Em. Rpt LSCS 
ST





l Nil Nil Nil Nil
22
2 Kasthuri 973 35F
Elder 




l Nil Nil Nil Nil
22




l Nil Nil Nil Nil
22










Primi Em. LSCS Failed Induction +
Ni










l Nil Nil Nil Nil
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22
7 Kalavathy 797 27F
G3 P1 L1 
A1
El. Rpt LSCS 




l Nil Nil Nil Nil
22
8 Maheswari 623 23F G2 P1 L1
El. Rpt LSCS 




l Nil Nil Nil Nil
22
9 Sundar 869 27F
G3 P1 L1 
A1 
Em. Rpt LSCS 




l Nil Nil Nil Nil
23
0 Sumathy 907 19F
G4 P2 L1 




l Nil Nil Nil Nil
23
1 Umamaheswari 988 20F Primi Em. LSCS Fetal distress Nil +
Ni








l Nil Nil Nil Nil
23
3 Vadivu 998 29F Primi Em. LSCS  FD Nil
Ni




4 Thenmozhi 882 21F Primi Em LSCS





l Nil Nil Nil Nil
23




l Nil Nil Nil Nil
23




l Nil Nil Nil Nil
23




l Nil Nil Nil Nil
23














Primi Em. LSCS PIH FD Nil +
Ni




0 Prema 983 23F G2 P1 L1
Em.Rpt LSCS 
ST





l Nil Nil Nil Nil
24
1 Rajeswari 828 19F







l Nil Nil Nil Nil
24
2 Vennila 968 18F G2 P1 L1
Elec Rpts LSCS 




l Nil Nil Nil Nil
24




l Nil Nil Nil Nil
24










5 Nagajothy 1050 19F
G4 P2 L2 




l Nil Nil Nil Nil
24
6 Joyee 940 24F G2 P1 L1
Em. LSCS with 




l Nil Nil Nil Nil
24
7 Sasikala 1038 17F
G3 P1 L1 




l Nil Nil Nil Nil
24




l Nil Nil Nil Nil
24




l Nil Nil Nil Nil
25
0 Dhanalakshmi 1046 20F G2  A1 Em. LSCS





l Nil Nil Nil Nil
25




l Nil Nil Nil Nil
25




l Nil Nil Nil Nil
25
3 Nazeema 4869 19F G2 P1 L1
Ele RPT LSCS 




l Nil Nil Nil Nil
25
4 Neelaveni 5864 23F G2 P1 L1
Ele RPT LSCS 




l Nil Nil Nil Nil
25
5 Selvi 6000 22F G2 P1 L1
Emer. RPT 
LSCS ST Prev.LSCS Nil +
Ni





6 Kanimozhi 5815 20F G2 P1 L1
Emer.Rpt LSCS 












l Nil Nil Nil Nil
25




l Nil Nil Nil Nil
25




l Nil Nil Nil Nil
26




l Nil Nil Nil Nil
26
1 Gajalakshmi 6023 21F
G2 P1 L1 Emer Rpt. 




l Nil Nil Nil Nil
26
2 Noornisha 6021 22F
G2 P1 L1 Emer Rpt. 




l Nil Nil Nil Nil
26
3 Chandrakala 6017 20F
G2 P1 L1 EmerRpt. LSCS 




l Nil Nil Nil Nil
26
4 Radhika 5912 21F Primi Emer. LSCS





l Nil Nil Nil Nil
26
5 Mohana 6042 23F Primi Emer. LSCS FD Nil
Ni








l Nil Nil Nil Nil
26
7 Rekku 6018 25F G2 P1 L1
Emer. Rpt 




l Nil Nil Nil Nil
26








9 Rajeswarai 5909 23F G3 P2 L2
Emer RPT. 




l Nil Nil Nil Nil
27




l Nil Nil Nil Nil
27
1 AdiLakshmi 5996 21F G2 P1 L1
Emer Rpt. 
LSCS ST Prev. LSCS Nil
Ni








l Nil Nil Nil Nil
27
3 Indra 5684 25F G2 P1 L1
Elective LSCS 




l Nil Nil Nil Nil
27




l Nil Nil Nil Nil
27
5 Elanselvi 5988 24F Primi Emer. LSCS FD Nil +
Ni








l Nil Nil Nil Nil
27




l Nil Nil Nil Nil
27
8 Mumtaj 6087 20F Primi Emer. LSCS Severe PIH Nil
Ni








l Nil Nil Nil Nil
28
0 Hemalatha 5965 27F Primi Emer. LSCS Failed Induction Nil +
Ni








l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
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28




l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
28




l Nil Nil Nil Nil
29




l Nil Nil Nil Nil
29




l Nil Nil Nil Nil
29
2 Kumari 5951 22F Primi Emer. LSCS Fail indi / PIH Nil +
Ni








l Nil Nil Nil Nil
29
4 Sasikala 6127 18F
G3 P1 L1 
A1 Emer. LSCS ST Prev. LSCS CPD Nil
Ni








l Nil Nil Nil Nil
29




l Nil Nil Nil Nil
29




l Nil Nil Nil Nil
29




l Nil Nil Nil Nil
29
9 Umadevi 6173 24F




l Nil Nil Nil Nil
30
0 Benitha 6172 27F




l Nil Nil Nil Nil
30
1 Sasikala 6187 27F




l Nil Nil Nil Nil
30
2 Suguna 6014 20F G2 P1 L1 Emer. LSCS ST Prev. LSCS Nil
Ni
l + Nil Nil Nil Nil
30




l Nil Nil Nil Nil
30
4 Radikha 6020 21F
G3 P1 L1 






5 Sudha 6005 24F G2 P1 L1
ElecRPT 




l Nil Nil Nil Nil
30




l Nil Nil Nil Nil
30
7 Solaiamma 6178 19F G2 P1 L1 Emer. LSCS MSAF / FD +
Ni










l Nil Nil Nil Nil
30
9 Samathanam 6192 18F
G4 P2 L1 




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
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31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31




l Nil Nil Nil Nil
31
9 Sathya 6275 18F Primi Emer. LSCS  MSAF +
Ni










l Nil Nil Nil Nil
32




l Nil Nil Nil Nil
32




l Nil Nil Nil Nil
32




l Nil Nil Nil Nil
32
4 Devi 6199 24F
G3 P1 L1 




l Nil Nil Nil Nil
32








l Nil Nil Nil Nil
32




l Nil Nil Nil Nil
32




l Nil Nil Nil Nil
32




l Nil Nil Nil Nil
33
0 Jayanthi 5947 23F G2 P1 L1
Elective LSCS 




l Nil Nil Nil Nil
33
1 Jyothi 6207 21F G2 P1 L1
Elective LSCS 




l Nil Nil Nil Nil
33




l Nil Nil Nil Nil
33
3 Kalavathi 6212 27F G2 P1 L1
Elective 




l Nil Nil Nil Nil
33




l Nil Nil Nil Nil
33
5 Saridha 6290 23F Primi Emer. LSCS





l Nil Nil Nil Nil
33




l Nil Nil Nil Nil
33




l Nil Nil Nil Nil
33




l Nil Nil Nil Nil
33




l Nil Nil Nil Nil
34
0 Poongodi 9266 24F
G3 P1 L1 




l Nil Nil Nil Nil
34
1 Meenachi 9607 23F Primi Emer. LSCS Arrest of Descent Nil +
Ni








l Nil Nil Nil Nil
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34




l Nil Nil Nil Nil
34




l Nil Nil Nil Nil
34




l Nil Nil Nil Nil
34
6 Loha Moses 9883 18F Primi Emeg  LSCS Severe PIH Nil
Ni










l Nil Nil Nil Nil
34
8 Malathy 9898 17F Primi Emg LSCS





l Nil Nil Nil Nil
34




l Nil Nil Nil Nil
35
0 Shobana Devi 9942 24F G2 P1 L1
Eny Rpt LSCS 
ST
Prev LSCSwith UE 
head +
Ni
























4 21F G2 P1 L1
Emeg. Rpt 
LSCS  ST Breech Nil +
Ni






















0 18F G3 P2 L2
Em. Rpt. LSCS 








8 18F G4 P3 L3 Em. LSCS ST Obstructed  labour Nil
Ni














0 19F G4 P3 L2
Em. Rpt. LSCS 








4 24F G2 P1 L1
Em. Rpt LSCS 

















Em RPT LSCS 








9 28F G2 P1 L1
Em RPT LSCS 


















8 26F G2 P1 L1
Em. RPT LSCS 
ST

















1 22F G2 P1 L0 Em. Rpt. LSCS






















































l Nil Nil Nil Nil
37
4 Poonga 9876 21F Primi Emer. LSCS Failed induction. Nil +
Ni








l Nil Nil Nil Nil
37
6 Kalaiselvi 9052 17F G2 P1 L1
Emer. RPT 




l Nil Nil Nil Nil
37
7 Geetha 9006 17F
G3 P1 L1 




l Nil Nil Nil Nil
37
8 Nagammal 8906 25F G2 P1 L1
Em. LSCS with 




l Nil Nil Nil Nil
37
9 Bhavani 9054 21F G2  A1 Em. LSCS CPD +
Ni








l Nil Nil Nil Nil
38




l Nil Nil Nil Nil
38




l Nil Nil Nil Nil
38




l Nil Nil Nil Nil
38




l Nil Nil Nil Nil
38












l Nil Nil Nil Nil
38
7 Vijayalakshmi 9081 25F G2 P1 L1





l Nil Nil Nil Nil
38
8 Faridha 9097 21F G2  A1 Em. LSCS
PIH / Failure to 
progress Nil
Ni








l Nil Nil Nil Nil
39
0 Devisudha 9131 20F Primi Em. LSCS Failure to progress Nil
Ni




1 Krishnaveni 9070 18F G2 P1 L1





l Nil Nil Nil Nil
39
2 Bhavani 9124 20F G2 P1 L1
Em. RPT LSCS 




l Nil Nil Nil Nil
39




l Nil Nil Nil Nil
39












l Nil Nil Nil Nil
39
6 Uma Maheswari 9153 22F Primi Em. LSCS Breech +
Ni






7 Geetha 9157 18F G2 P1 L1





l Nil Nil Nil Nil
39
8 Muthulakshmi 9176 22F G2 P1 L1





l Nil Nil Nil Nil
39
9 Roja 9182 21F G2 P1 L1
Em. RPT LSCS 




l Nil Nil Nil Nil
40




l Nil Nil Nil Nil
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40
1 Umamaheswari 9196 18F
G3 P1 
L1A1
Em. LSCS with 
ST CPD +
Ni




2 Afras begum 9201 20F
G2 P1 




l Nil Nil Nil Nil
40
3 Anusuya 9139 28F G2 P1 L1
Emer. Rpt. 
















































5 19F Primi Emer. LSCS PIH CPD +
Ni














9 21F G2 A1 Emer. LSCS CPD Nil +
Ni






9 23F G2 P1 L1
Emer. Rpt. 









G3 P2 L1 








































9 24F Primi Emer. LSCS Failed Induction +
Ni










l Nil Nil Nil Nil
42








7 22F G2 P1 L1
EM RPT LSCS 








8 26F G2 P1 L1
EM Rpt . LSCS 










































F G2 P1 L1
Emg. Rpt LSCS 




l Nil Nil Nil Nil
42
8 Prabavathy 9708 23F Primi Emer. LSCS Failure to Progress +
Ni








l Nil Nil Nil Nil
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43
0 Shakuntala 9694 24F G4 P3 L1
Emer. Rpt. 




l Nil Nil Nil Nil
43
1 Selvi Raguls 9916 23F Primi Emer. LSCS CPD Nil +
Ni














9 26F G2 P1 L1
Emer. Rpt 








7 27F G2 P1 L1
Emer.Rpt LSCS 
ST

















6 26F G2 P1 L1
Emer.Rpt LSCS 
ST

































1 22F G2 P1 L1
Emer. LSCS 
with ST Prev. LSCS UE head +
Ni






7 28F G3 P2 L2
Emer. Rpt 
























8 26F G2 P1 L1
Emer. Rpt 
















9 20F Primi Emer. LSCS Ffailure to progress +
Ni






















4 28F Primi Emer. LSCS Fetal distress +
Ni






































2 20F G2 P1 L1
Em. Rpt LSCS 








9 20F Primi Em. LSCS
Long Pd of infertility / 
PIH +
Ni






















3 19F G2 P1 L1
El. Rpt LSCS 













































































0 26F Primi Emg. LSCS Failure to progress +
Ni














8 25F Primi Emg. LSCS









2 18F G2 P1 L1 Emer. LSCS










G3 P1 L0 
A1 Ele. LSCS









3 20F Primi Emg. LSCS Fetal Distress +
Ni






































8 18F Primi Emg. LSCS CPD +
Ni






6 25F G2 P1 L1 Emg. LSCS




































G3 P1 L1 
A1 
Emg. LSCS with 
















5 23F G2 P1 L1
Emg. LSCS with 









G3 P1 L1 
A1 
Emg. LSCS with 












































































































































4 23F G3 P2 L2
Emg. LSCS with 




l Nil Nil Nil Nil
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KEY FOR MASTER CHART
FD : Fetal Distress
CPD : Cephalo Pelvic Disproportion
PIH : Pregnancy Induced Hypertension
LSCS : Lower Segment Caesarean Section
PP : Placenta Previa
MSAF : Meconium Stained Amniotic Fluid
BOH : Bad Obstetric History
ST : Sterilisation 
FI : Failed Induction 
IE : Imminent Ecclampsia
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